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Summary 
This thesis deals with conjugation of plasmids harbouring tetracycline or erythromycin resistance 
genes from wild-type lactobacilli to other bacteria relevant to the human gut. Conjugal transfer and 
factors affecting transfer has been evaluated both in vitro and in different animal models simulating 
the human gastrointestinal (GI) tract. The experimental work encompasses aspects trying to 
elucidate the extent of antibiotic resistance gene dissemination mediated by lactobacilli - both by 
means of transfer frequency giving an estimate of the quantitative contribution as well as the 
pathways of transfer, hereunder potential recipient bacteria. An assessment of selective pressure 
with antibiotics both at sub-inhibitory concentrations and concentrations simulating clinical doses 
and its effect on distribution of antibiotic resistance plasmids is also included. Additionally, a more 
mechanistic point of view has been applied with emphasis on plasmid genetic factors amongst 
others responsible for transfer, determination of host-range, expression of antibiotic resistance and 
regulation of plasmid replication.    
 
The present thesis consists partly of a theoretical overview incorporating available literature 
concerning the subject and partly of three enclosed manuscripts accounting for important selected 
results obtained during the project.  
Main areas in the theoretical part are application and action of antibiotics and development of 
antibiotic resistance, including pathways of dissemination and resistance mechanisms. Furthermore, 
a paragraph has been devoted to gene transfer in bacteria looking more into the genetic basis of 
transferable DNA elements and their interaction with bacterial hosts. Lastly, antibiotic resistance 
gene transfer in the human GI tract and specific models, which can be applied to study this, are 
discussed. In the theoretical overview, special emphasis has been paid to the antibiotics tetracycline 
and erythromycin as well as lactobacilli, conjugation and rolling-circle replicating plasmids, since 
these belong to subjects practically investigated in this project.  
 
In Paper I, two wild-type Lactobacillus plantarum strains, DG 507 and DG 522, isolated from 
Belgian fermented sausages and harbouring native transferable plasmids conferring erythromycin 
and tetracycline resistance were tested for their ability to function as donors in a gastrointestinal 
environment. Germ-free rats were associated with an Enterococcus faecalis recipient and used as a 
model to simulate a worst-case scenario of transfer in the human GI tract. Following colonization of 
the recipient, each of the two donor strains was administered to the rats, and from the second day 
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onwards, faecal samples containing transconjugants were derived from either donor. The study 
documented the ability of both Lactobacillus strains to facilitate conjugation after being subjected 
to physical factors resembling those encountered in the human GI tract after ingestion.  
 
In Paper II, transfer of wild-type plasmid pLFE1 carrying an erythromycin resistance gene was 
investigated in a di-associated rat model, as described for manuscript 1. First, an E. faecalis 
recipient was allowed colonization in the rats and thereafter a wild-type donor strain Lactobacillus 
plantarum M345, isolated from a French raw-milk cheese and carrying pLFE1, was introduced. 
Dissemination of pLFE1 was examined in three groups of rats receiving either erythromycin at 
concentrations simulating clinical doses, 1/10 of clinical doses or no treatment, respectively. 
Transconjugants were observed in all three groups, however transfer and establishment of pLFE1 
were considerably enhanced in rats administered erythromycin, irrespective of dose. Practically all 
E. faecalis recipients received pLFE1 within one day in the erythromycin-treated rats, whereas four-
to-five days were needed to reach a stable transconjugant population at significantly lower numbers 
in the non-treated rats. In addition to selection by growth, the strong favouritism of pLFE1 provided 
by erythromycin could possibly be explained with an increased transfer frequency. Yet, selective 
pressure with erythromycin was not a prerequisite for maintenance of pLFE1, because 
transconjugants persisted in the gut at relatively stable numbers at least 12 days after termination of 
antibiotic administration.  
The GI tract was suggested to constitute a more favourable environment for conjugative plasmid 
transfer than in vitro, since in spite of low filter-mating frequency (~5.7 × 10-8 
transconjugants/recipient) relatively high numbers of transconjugants (10-4 
transconjugants/recipient) were observed in vivo, even in the non-treated rats. In order to investigate 
transfer of pLFE1 in a more complex model comprising an impaired colonization barrier, a similar 
experiment was set-up using streptomycin-treated mice. No transfer to the E. faecalis recipient was 
detected in this experiment, stressing the ability of the indigenous microbiota to reduce 
dissemination.    
 
In Paper III, the 4031 bp nucleotide sequence of the small plasmid pLFE1 was determined and 
analysed. The sequence revealed an erm(B) gene coding for an erythromycin ribosome methylase 
conferring erythromycin resistance and the presence of a small erythromycin leader peptide 
suggested that expression of resistance may be inducible.  
 4
Plasmid pLFE1 was suggested to belong to the pMV158 family of rolling-circle-replicating (RCR) 
plasmids, containing a putative replication initiation protein RepB characteristic of this family. Two 
putative elements (a transcriptional repressor protein CopG and a small countertranscribed RNA, 
ctRNA), typically involved in control of RepB and thereby copy number within the pMV158 
family, were also detected. A potential replication initiation site was pointed out including a double-
strand origin displaying compatibility with RepB and a single-strand origin. Moreover, the presence 
of a secondary replication initiation site was suggested.  
A sequence coding for a putative truncated mobilization protein with similarity to the pMV158 
family of Pre/Mob proteins was detected. However this protein was regarded non-functional and 
mobilization of pLFE1 was therefore believed to require the presence of another Mob protein in 
trans.  
The nucleotide sequence analysis was accompanied by practical filter-mating studies in order to 
determine the ability of pLFE1 to be transferred to and replicate in different species of Gram-
positive bacteria. pLFE1 was shown to have a broad host-range, obtaining transconjugants from 
mating between donor L. plantarum M345 and recipients of Lactobacillus rhamnosus, Lactococcus 
lactis, Listeria innocua, Enterococcus faecalis and Listeria monocytogenes.  
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Resumé (Danish abstract) 
Dansk titel: Overførsel af oprindelige plasmider indeholdende tetracyklin eller erythromycin 
resistensgener fra naturligt forekommende Lactobacillus plantarum stammer til andre bakterier i et 
tarmmiljø  
 
Denne rapport omhandler overførsel af plasmider vha. konjugation fra naturlige laktobaciller til 
andre bakterier af relevans for den humane tarm. Plasmiderne indeholder gener, der koder for 
resistens overfor tetracyklin eller erythromycin. Konjugativ overførsel og faktorer som påvirker 
overførslen er blevet undersøgt in vitro, samt i forskellige dyremodeller, der simulerer den humane 
mave-tarm kanal. Det eksperimentelle arbejde omfatter aspekter, som forsøger at kaste lys over 
omfanget af laktobacillers medvirken til udbredelse af antibiotikaresistensgener. Dette inkluderer 
både overførselsfrekvenser der giver et skøn af den kvantitative udbredelse, samt ruter for 
overførsel, herunder hvilke bakterier der optræder som mulige recipienter. En vurdering af 
antibiotikas selektive virkning, både i koncentrationer under det hæmmende niveau og i 
koncentrationer der simulerer kliniske niveauer, er også medtaget. Derudover, er der antaget et mere 
mekanistisk synspunkt med fokus på de genetiske faktorer for plasmider, der bl.a. er ansvarlige for 
overførsel, bestemmelse af værtsspektrum, ekspression af antibiotikaresistens og regulering af 
replikation. 
 
Denne rapport består dels af et teoretisk sammendrag baseret på tilgængelig litteratur indenfor 
området og dels af tre manuskripter, som redegør for vigtige udvalgte resultater opnået gennem 
projektet. 
Hovedområderne i den teoretiske del er brug og virkemåder af antibiotika samt udvikling af 
antibiotikaresistens, inklusive ruter for udbredelse og resistensmekanismer. Derudover findes et 
afsnit omhandlende genoverførsel hos bakterier, hvor der bliver set mere i detaljer på den basale 
genetik for mobile DNA elementer samt interaktioner med deres bakterielle værter. Endeligt 
diskuteres overførsel af antibiotikaresistensgener i det humane mave-tarm system samt specifikke 
modeller, der kan anvendes til at studere dette. I den teoretiske oversigt bliver der sat ekstra fokus 
på tetracyklin og erythromycin samt på laktobaciller, konjugation og rolling-circle replikerende 
plasmider, idet de praktiske studier specielt har koncentreret sig om dette. 
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Manuskript I, havde til formål at teste to naturligt forekommende Lactobacillus plantarum 
stammers (DG 507 og DG 522, isoleret fra belgiske fermenterede pølser) evne til at fungere som 
donorer af oprindelige plasmider indeholdende erythromycin og tetracyklin resistensgener i et 
mave-tarm miljø. Kimfri rotter blev inokuleret med en Enterococcus faecalis recipient og brugt som 
model til at efterligne et scenarie for højst tænkelig overførsel i den humane mave-tarm kanal. Efter 
kolonisering med recipienten blev hver af donorstammerne introduceret og efter to dage kunne 
transkonjuganter detekteres i fæcesprøverne. Dette studie dokumenterede begge L. plantarum 
stammers evne til at overføre antibiotikaresistensgener vha. konjugation efter påvirkning af fysiske 
faktorer, svarende til dem der findes i den humane mave-tarm kanal.   
 
I Manuskript II, blev overførsel af det naturligt forekommende plasmid pLFE1, indeholdende et 
erythromycin resistensgen, studeret i en di-associeret rottemodel, som beskrevet for manuskript I. 
Først blev rotterne koloniseret med en E. faecalis recipient og derefter blev donorstammen L. 
plantarum M345 (isoleret fra en fransk råmælksost og indeholdende pLFE1) introduceret. 
Udbredelsen af pLFE1 blev undersøgt i tre grupper af rotter, der henholdsvis blev behandlet med 
erythromycin i koncentrationer der simulerer klinisk behandling, 1/10 af klinisk behandling eller 
ingen behandling. Transkonjuganter blev observeret i alle tre grupper, men overførslen og 
etableringen af pLFE1 var tydeligt forbedret i de grupper, der havde modtaget erythromycin – 
uanset dosis størrelse. Stort set alle E. faecalis recipienter modtog pLFE1 indenfor den første dag i 
erythromycin-behandlede rotter, hvorimod det varede 4-5 dage at nå en stabil population og i et 
signifikant lavere antal for de ubehandlede rotter.
 
Den
 
stærke selektion af pLFE1 forårsaget af 
erythromycin kan foruden vækstfordelen muligvis forklares med en øget overførselsfrekvens. 
Selektivt pres med erythromycin var dog ikke en forudsætning for opretholdelse af pLFE1, da 
antallet af transkonjuganter i tarmen forblev relativt stabilt selv 12 dage efter endt 
antibiotikabehandling. 
Mave-tarm kanalen udgjorde tilsyneladende et mere favorabelt miljø for konjugativ overførsel af 
plasmider end in vitro, idet et relativt højt antal transkonjuganter (10-4 transkonjuganter/recipient) 
kunne observeres in vivo, selv i ubehandlede rotter, til trods for en lav overførselsfrekvens in vitro 
(~5.7 × 10-8 transkonjuganter/recipient). For at undersøge overførsel af pLFE1 i en mere kompleks 
model med en svækket koloniseringsmodstand, blev et tilsvarende forsøg udført med streptomycin-
behandlede mus. I dette forsøg kunne der ikke detekteres nogen overførsel til E. faecalis 
recipienten, hvilket understreger den naturlige mikrobiotas evne til at reducere overførsel.  
 7
 
I Manuskript III, blev den 4031 bp lange nukleotidsekvens for det lille pLFE1 plasmid bestemt og 
analyseret. Sekvensen rummede et erm(B) gen kodende for en erythromycin ribosom methylase, der 
giver resistens overfor erythromycin, og et lille erythromycin leader peptid, hvis tilstedeværelse 
antydede at ekspression af resistensen kan være inducerbar. 
Plasmidet pLFE1 tilhører angiveligt pMV158 familien af rolling-circle replikerende (RCR) 
plasmider, indeholdende et potentielt replikationsprotein, RepB, som er karakteristisk for denne 
familie. To elementer (et protein CopG, som undertrykker transskription og et lille RNA (ctRNA) 
transskriberet i modsat retning), der typisk er involveret i kontrol af RepB og dermed antal plasmid-
kopier i pMV158 familien, kunne også detekteres. Et muligt område for initiering af replikation, 
indeholdende et origin for dobbeltstrenget DNA, der er kompatibelt med RepB og et origin for 
enkeltstrenget DNA, blev identificeret. Derudover blev tilstedeværelsen af et sekundært område for 
initiering af replikation foreslået.  
En sekvens kodende for et potentielt trunkeret mobiliseringsprotein i lighed med Pre/Mob proteiner 
fra pMV158 familien blev også fundet. Dette protein blev dog ikke regnet for funktionsdygtigt, og 
derfor formodedes det, at mobilisering af pLFE1 kræver et andet Mob protein i trans.  
Analysen af nukleotidsekvensen blev ledsaget af filter-mating studier, for at undersøge hvorvidt 
pLFE1 kan overføres til og replikere i andre arter af Gram-positive bakterier. Det blev vist at 
pLFE1 har et bredt værtsspektrum, idet der blev observeret transkonjuganter fra mating mellem 
donorstammen L. plantarum M345 og recipienter af Lactobacillus rhamnosus, Lactococcus lactis, 
Listeria innocua, E. faecalis og Listeria monocytogenes.   
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1. General Introduction  
1.1 Background 
An alarming problem exists on antibiotic resistance and increasing inability to cure infections of 
resistant pathogenic bacteria. In recent years focus has been directed towards commensal bacteria 
including lactic acid bacteria such as lactobacilli, and their contribution to dissemination and 
persistence of this problem. Immense support has accumulated for the argument that commensal 
bacteria act as reservoirs for antibiotic resistance genes found in pathogens. This amongst others 
owes to the fact that similar resistance determinants can be found across the “border” of 
pathogenicity, connecting resistance in e.g. lactobacilli with pathogenic streptococci. However, the 
pathways for these genetic linkages and the extent of antibiotic resistance transfer mediated by 
genera such as Lactobacillus are poorly understood.   
The main pathway for exposure to lactobacilli is via ingestion. Lactobacilli are very important 
players in industrial food and feed production. They are often associated with a health benefit for 
human and animals, and many species within this group have a generally recognized as safe 
(GRAS) status. Yet, subsequent to ingestion lactobacilli may colonize the gastrointestinal (GI) tract 
becoming a part of the indigenous microbiota and/or interact with other members of the microbiota 
transferring antibiotic resistance genes.  
Lactobacilli present in food can be either deliberately amended or occur as a result of contamination 
during processing. When a strain is amended to a certain product, it can be present in high numbers 
and its distribution follows that of the product. Potential antibiotic resistance problems associated 
with such strains may therefore have widespread implications. Industrial producers generally are 
very careful to avoid transferable antibiotic resistance genes in their starter and probiotic strains. To 
date, strains exhibiting resistance may be discarded, since ultimate proof of immobility of the 
resistance determinant can be difficult to provide. Still, by improving ability to estimate the risk 
associated with antibiotic resistance in Lactobacillus spp., companies may have an easier task 
developing and assessing new production strains. Furthermore, improving identification of strains 
posing actual risks may lead to a more firm legislation ensuring rejection of these.  
Lactobacilli are common indigenous members of the gastrointestinal microbiota of various animals 
as well as humans. An important source of contamination with lactobacilli in food of animal origin 
is therefore through faecal contamination of raw-products. If the food is produced without 
pasteurisation or heat-treatment, which is the case for e.g. fermented sausages and ham and cheese 
or dairy products produced from raw-milk, survival and thus carry-over of contaminating bacteria to 
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the final ready-to-eat products may occur. Most European producers have very hygienic processing 
equipments and make a strong effort to avoid contamination of food-products. Nevertheless, 
complete avoidance of carry-over is not feasible. Basal knowledge of the risk associated with 
antibiotic resistant lactobacilli in food is therefore required.  
Precautionary measures that have been taken in order to limit the flux of antibiotic resistant bacteria 
from animals to humans are for instance restrictions in the use of antibiotics as animal growth 
promoters. Yet, there is still a large overuse of antibiotics in many areas and it is well known that 
selective pressure induced by antibiotics leads to development and spread of antibiotic resistance. 
Understanding of the magnitude of antibiotic resistance dissemination mediated by lactobacilli and 
the effect of antibiotic pressure is however inadequate and more research is needed in this area.  
 
1.2 Objectives of this work 
The main aim of this Ph.D.-project was to study the potential for conjugation of plasmids 
harbouring antibiotic resistance genes from Lactobacillus to other bacteria in the human GI tract. 
Two aspects of this potential were considered namely the qualitative and the quantitative extent of 
transfer.  
The qualitative assessment included examination of the ability of Lactobacillus strains to transfer 
resistance determinants per se and investigation of the pathways for spread of the plasmids. In this 
respect, the spectrum of different bacteria that may act as recipients and the potential of these to 
function as secondary distributors were analysed. Amongst potential recipients, the primary focus 
was held on Gram-positive species of relevance to the human GI tract, including commensals as 
well as opportunistic pathogens and pathogens.   
Estimation of the quantitative extent of transfer in the human GI tract was another objective of this 
work. For this purpose, conjugation studies were set up in more or less complex environments in 
order to approach conditions in the human GI tract. Furthermore, it was intended to learn more 
about the effect of sub-inhibitory concentrations or clinical treatment with antibiotics on the transfer 
frequency and persistence of antibiotic resistance in the GI tract.  
 
1.3 Research approach 
Pilot experiments were performed on a number of antibiotic resistant Lactobacillus spp. in order to 
identify strains with traceable transfer capacity. These strains were used as donors in in vitro filter-
mating experiments using primarily Enterococcus faecalis as recipient. E. faecalis is a common 
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member of the indigenous human microbiota, an opportunistic pathogen and known to be an 
efficient recipient of genetic mobile elements. Positive verification of transfer could be obtained for 
a limited number of donors including three wild-type strains of Lactobacillus plantarum, which 
were chosen as model organisms for further examination. These “models” had been isolated from 
fermented sausage and raw-milk cheese and harboured transferable plasmids conferring resistance 
to tetracycline, erythromycin or both. 
In order to investigate dissemination of resistance plasmids after ingestion, in vivo experiments 
were set up using germ-free rats to simulate physical conditions encountered in the human GI tract. 
The rats were di-associated with an E. faecalis recipient and either of the donor models, as to allow 
maximal population densities of test bacteria and thus constitute worst-case scenarios representing 
upper limits of transfer. The rats were divided into groups receiving no antibiotics (controls), sub-
inhibitory or clinical doses. Results were compared with those from experiments conducted on 
streptomycin-treated mice applying similar protocols, in order to assess the effect of a colonization 
barrier.  
To facilitate a better understanding of some of the factors determining e.g. mobilization and the 
quantitative dissemination as well as the host-range of plasmid transfer observed for model strain L. 
plantarum M345 in vivo and in vitro, sequencing and analysis of the respective plasmid pLFE1 was 
performed.  
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2. Antibiotics 
2.1 Problems with antibiotic resistance  
The major risk of antibiotic resistance is obviously failure of treatment of a specific infection. 
Antibiotic resistant infections can result in increased morbidity due to a delay in the curing-process 
if the first choice of antibiotic fails or due to accompanying diseases caused by the antibiotic 
treatment. In some instances, treatment in due time is mandatory, and an unsuccessful attempt of 
curing will be mortal. In other cases, alternative treatments may be absent or insufficient for 
instance due to multi-resistant infections. An earlier study estimated that the duration of hospital 
stays, the morbidity and the mortality were doubled compared with antibiotic-susceptible infections 
(Holmberg et al. 1987). However, the extent and costs of antibiotic resistance is very difficult to 
assess and probably vary considerably depending on e.g. the knowledge of resistance patterns of the 
infectious agent and the current antibiotics available. In all circumstances, antibiotic resistance has 
great economic and societal implications and poses a radical threat to human and animal health.   
It is well established that the extent of antibiotic usage is tightly linked to development of antibiotic 
resistance and introduction of new compounds on the market is by convention followed by 
emergence of bacterial resistance (Levy and Marshall 2004). Exposing bacteria to antibiotics results 
in a selective advantage to those, which have developed or acquired resistance towards it, and the 
resistant bacteria can therefore spread at the expense of the sensitive ones (Moubareck et al. 2003). 
The nature of selection should result in practical action in compliance with guidelines for the 
prudent use of the antibiotics, in order to retain their activity. For clinical use, this means a proper 
diagnosis, careful choice of antibiotic agent that preferably should have a narrow range of activity 
and time- and dosis-controlled accomplishment of treatment. In modern food animal production 
antibiotics are also used in large amounts and dissemination of antibiotic resistant bacteria from 
these animals to humans is possible via the food chain. The antibiotics can be used in any of four 
different ways, (i) therapy of clinically sick animals, (ii) metaphylactics, which is treatment of 
healthy animals present in a pen including sick animals, (iii) prophylactics, which is preventive 
treatment of animals exposed to stressed situations or (iv) growth promotion, which is continuous 
application of antibiotics at subtherapeutic concentrations to feeds in order to improve animal 
growth (Aarestrup 2005).    
Especially the application of antibiotics as growth promoters in animal husbandry has received a lot 
of criticism. The sole objective of growth promotion is an economic gain by obtaining a faster meat 
production line. The way to achieve this is by long-term feeding with antibiotics at low 
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concentrations, which is associated with an extended risk of resistance development. Despite 
difficulties in providing direct evidence that the ultimate outcome of this procedure is an increase in 
antibiotic resistant human pathogens, the precautionary principle led to a more strict legislation in 
EU. Hence, in 1970, the European Commission banned tetracycline as an agent for growth 
promotion. Sweden thereafter acted as a pioneer nation taking up a more progressive attitude 
against antibiotics for growth promotion by proclaiming a total ban in 1986. Detection of 
vancomycin resistant enterococci in food animals led the Danish food industry to decide on a 
voluntary abolishment of the growth promoter avoparcin in 1995, in order to prevent cross-
resistance to the important human drug vancomycin (Aarestrup 2000). In the late 1990s, the 
European Commission extended their ban to include drugs relevant for human therapy or capable of 
causing cross-resistance to therapeutically relevant agents (Chopra and Roberts 2001) and from 
January 2006 a total abolishment of antibiotics used for animal growth promotion was decided 
(European Commission 2005). In most countries outside Europe however, restrictions on this area 
are lacking behind. 
A large number of studies and also nationwide monitoring programs have investigated the effect on 
antibiotic resistance after cessation of antibiotic use (Aarestrup et al. 2001;Boerlin et al. 2001;Klare 
et al. 1999;Seppala et al. 1997;Van Den Bogaard et al. 2000). Generally, these studies report a 
decrease in the occurrence of resistance after removal of the selective pressure. However, some 
studies have shown status quo conditions, which in many cases have been assigned to co-selection 
of the antibiotic resistance determinant either by coupling of the determinant with other antibiotic 
resistance markers, heavy-metal resistances etc. Since the metabolic burden of maintaining the 
resistance determinants sometimes is relatively low, the loss of resistance can also be very slow, 
and even after a long time resistant isolates may persist in the environment. This resistant 
subpopulation can after recurring selection very quickly grow to reach initial numbers (Levy and 
Marshall 2004).  
It has been suggested that the fastest way to eliminate resistant isolates is to out-compete and 
replace them with susceptible ones (Levy and Marshall 2004). The success of this strategy depends 
on the availability of susceptible strains in the adjacent environment. Thus, a chicken, which 
belongs to a flock with high resistance preference or a patient on a hospital surrounded by other 
patients in antibiotic treatment, may continuously be reinfected with resistant isolates. Therefore, a 
global effort to limit the use of antibiotics is necessary to control antibiotic resistance dissemination.   
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2.2 Routes of antibiotic resistance dissemination 
Bacteria are a ubiquitous part of our surroundings and there is a continuous movement and 
exchange either faster or slower in the bacterial populations inhabiting different environments. The 
main focus of this Ph.D project has been on dissemination of antibiotic resistance within the food 
chain with special emphasis on transfer from lactic acid bacteria present in ingested food to bacteria 
inhabiting the human GI tract. The following paragraph will therefore be limited to discuss genetic 
exchange related to this area.  
During the last decade, increasing attention has been paid to the relevance of commensal bacteria 
acting as a pool of antibiotic resistance genes for human pathogens (Levy and Marshall 
2004;Mathur and Singh 2005;Salyers and Shoemaker 1996;Teuber et al. 1999;Teuber and Perreten 
2000). The main pathway for human uptake of bacteria and transportation to the GI tract is via the 
food chain. Food products contain bacteria that can be either deliberately amended to initiate food 
ripening, add flavour etc, or which are present due to contamination of the products during 
processing. In the case of deliberate addition of bacteria, knowledge of antibiotic resistance is of 
course much easier to achieve and generally strictly controlled by the modern food producers. 
However, in some, mainly smaller production facilities of e.g. cheese, the food processing occurs 
after old traditions involving back-sloping of a non-defined bacterial culture. These facilities 
commonly have a long history of safe use, but the non-defined bacterial starter culture may be 
associated with a higher risk if it consists of commensals carrying antibiotic resistance determinants 
(Maietti et al. 2007).  
In food based on animal products such as meat and milk, carry-over of bacteria from animal skin 
and faeces to the raw-products is inevitable during milking and slaughtering. If the contaminated 
raw-products are not sufficiently heat-treated by pasteurization of the milk or cooking of the meat, 
the bacteria will be directly transported to the human intestine after ingestion, where they may 
colonize and/or interact with the resident microbiota by disseminating resistance genes. Raw-milk 
cheeses and fermented sausages are examples of products that generally are associated with higher 
numbers of animal transmitted bacteria, since the relatively gentle manufacturing procedure allows 
for survival or even multiplication of these into the final ready-to-eat product (Teuber and Perreten 
2000). This exchange of bacteria from animals via the food to the consumers has been suggested to 
contribute significantly to human antibiotic resistant infections, especially when enteric organisms 
are involved (Levy and Marshall 2004). 
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2.3 Use of antibiotics 
2.3.1 Macrolides  
Macrolides are a group of natural or semisynthetic antibiotics composed of a lactone ring of 
variable size to which one or more sugars and/or amino groups are attached via glycosidic bonds 
(Table 1)(Mazzei et al. 1993). The prototype of macrolides is erythromycin, which is produced by 
Saccharopolyspora erythraea and was the first compound of the group to be introduced in 1952 
(Roberts et al. 1999). In the 1980s, semisynthetic derivatives of erythromycin were developed 
including the clinically important roxithromycin, clarithromycin and azithromycin, which 
essentially shared the antibiotic mechanism of action but had improved pharmacokinetic abilities, 
less adverse effects and a broader spectrum of activity (Roberts 2004). Other compounds belonging 
to the class are the 16-membered macrolides, which are only available in certain countries, e.g. 
spiramycin and tylosin used for animal growth promotion (Leclercq 2002).  
 
Table 1: Common natural and semisynthetic macrolide antibiotics  
lactone ring natural   semisynthetic 
14-membered erythromycin dirithromycin 
roxithromycin 
clarithromycin 
15-membered  azithromycin 
16-membered josamycin 
midecamycin 
spiramycin  
rokitamycin 
miocamycin 
tylosin 
Revised from (Mazzei et al. 1993) with changes adapted from (Leclercq 2002). 
 
The macrolides are active against Gram-positive bacilli and cocci including Streptococcus 
pneumoniae, Streptococcus pyogenes and Staphylococcus aureus as well as Gram-negative 
diplococci such as Neisseria gonorrhoeae. Furthermore, they inhibit Chlamydia trachomatis and 
some species of Mycoplasma and Chlamydophila (Lægemiddelkataloget 2008). Gram-negative 
bacilli are generally resistant to macrolides because the outer membrane offers protection from 
penetration by these hydrophobic compounds (Russell and Chopra 1990). However, some important 
exceptions are e.g. Legionella spp., Campylobacter jejuni and Helicobacter pylori (Leclercq 2002). 
Some of the semisynthetic derivatives show a broader range of activity than that of erythromycin, 
particularly clarithromycin with a greater potency against anaerobic bacteria and azithromycin with 
the inclusion of e.g. some Gram-negative enteric bacilli and Haemophilus spp. (Leclercq and 
Courvalin 1991). 
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Macrolides are primarily used to treat patients that are intolerant to penicillins and are suffering 
from e.g. pneumoni, tonsillitis, otitis, sinusitis and wound infections caused by Streptococcus 
pneumoniae or β-hemolytic streptococci. Furthermore the macrolides and especially azithromycin 
are used to threat infections of the urinary tract and cervix caused by Chlamydia and has also been 
effective in the treatment of gonorrhoea, however, the application for the latter purpose is declining 
due to increasing resistance (Lægemiddelkataloget 2008). 
In Denmark, the overall consumption of macrolides for human clinical treatment decreased by 4.2% 
in 2006 compared to 2005. This decrease was primarily due to a decrease in the use of 
erythromycin, which has been slightly but constantly decreasing since 1998. Furthermore, the 
development in the last years increasing consumption of roxithromycin was arrested from 2005 to 
2006. Despite the decreasing amount of consumed macrolides, this group of antibiotics still remains 
to be the third most used in the Danish primary health care sector with an annual consumption in 
2006 corresponding to 2.31 defined daily doses (DDD) per 1000 inhabitant-days. In the hospital 
sector the consumption of macrolides for nosocomial infections also decreased to represent 4.5% of 
the total consumption in 2006 (DANMAP 2006).   
The way of antibiotic action is similar in all macrolides, however there is small variations in their 
antibiotic spectrum and considerable differences in their pharmacokinetics. The clinical use of 
erythromycin is associated with much more adverse effects than that of the other macrolides 
clarithromycin, roxithromycin and azithromycin (Lægemiddelkataloget 2008). In the new Danish 
guidelines from 2006, clarithromycin is recommended as the first-choice of macrolides (DANMAP 
2006). 
 
2.3.2 Tetracyclines 
The first tetracyclines to be discovered were chlortetracycline and oxytetracycline, which were 
derived as naturally occurring products from different species of the soil bacterium Streptomyces in 
1948. Several other derivatives including semisynthetic molecules have been marketed over the 
years in order to improve and increase the applicative abilities of the tetracycline group and to 
circumvent problems with resistance to the older analogs (Table 2). After a long period with 
increasing resistance to the existing tetracycline compounds and no new products on the market, the 
US food and Drug Administration (FDA) approved tigecycline for human clinical trials in 2005. 
Tigecycline is the first compound belonging to a new generation of tetracycline derivatives named 
glycylcyclines (Doan et al. 2006). 
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Table 2: Principal members of the tetracycline class. 
Generation Generic name Origin               Year of discovery   Status 
 Chlortetracycline S. aureofaciens 1948 marketed 
 Oxytetracycline S. rimosus 1948 marketed 
I Tetracycline S. aureofaciens, S. rimosus,  S. viridofaciens 1953 marketed 
 Demethylchlortetracycline S. aureofaciens 1957 marketed 
 Rolitetracycline semisynthetic 1958 marketed 
 Limecycline semisynthetic 1961 marketed 
 Methacycline semisynthetic 1965 marketed 
II Doxycycline semisynthetic 1967 marketed 
 Minocycline semisynthetic 1972 marketed 
III Tigecycline semisynthetic 1993 marketed 
Adapted from (Chopra and Roberts 2001) with minor updates. 
 
Tetracyclines are broad-spectrum agents with activity against both Gram-positive and Gram-
negative bacteria as well as chlamydiae, mycoplasmas, Rickettsiae, protozoan parasites etc. Due to 
their wide range of activity, low cost and absence of noteworthy side effects, the tetracyclines have 
been extensively used for treatment of many different human and animal infections, but their 
applications also includes prophylactic use against malaria, control of infections in aquaculture, 
fruit production, growth promotion in animal husbandry and many other (Chopra and Roberts 
2001). The first tetracyclines were approved by FDA for animal growth promotion in 1951 and the 
amount of drugs added at subtherapeutic levels to animal feeds since then has been excessive 
(Chopra and Roberts 2001). In Europe tetracyclines were banned as growth promoters in the early 
1970s, however tetracyclines are still used for animal growth promotion in many countries outside 
Europe.  
Tetracyclines can be used in the treatment of various infections of the respiratory tract, urinary tract, 
bowel and many other local and systemic diseases. However, the applicability of these drugs has 
experienced a severe reduction due to increasing resistance in the causative organisms. Still, 
tetracyclines are important agents especially against community-acquired infections. In Denmark 
they belong to the fourth most used class of antibiotics in the primary health care section 
representing 1.38 DDD per 1000 inhabitant-days in 2006. Tetracycline and doxycycline composed 
the majority of consumed tetracyclines and was primarily used for the treatment of acne and for 
malaria prophylaxis, respectively (DANMAP 2006). 
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2.4 Mechanisms of antibiotics and countermoves of resistance 
2.4.1 Macrolides 
Macrolides are protein-inhibiting antibiotics, which function by binding to the bacterial 50S 
ribosomal subunit in a reversible manner, thereby inhibiting peptide elongation and thus exercising 
a bacteriostatic effect. Although the macrolides are structurally unrelated to the lincosamides and 
streptogramin B antibiotics, their binding sites within the bacterial ribosome are overlapping. 
Therefore, dependent on the resistance mechanism, the host bacteria show resistance either to one, 
two or all three groups of antibiotics. The mechanisms of acquired resistance genes towards these 
antibiotics include rRNA methylases, which function by ribosomal protection, efflux proteins and 
several different inactivating enzymes (Table 3). The former mechanism confers resistance towards 
all three groups, whereas the latter two normally confer resistance to only one or two of the groups 
(Roberts 2004).  
 
Table 3: Mechanism of resistance for characterized MLS resistance genes. Revised from (Roberts 2008).  
Ribosomal protection, n = 32 Efflux, n = 14 Enzymatic inactivation, n = 6 
rRNA methylasesa ATP-transporters or major 
facilitatorsb 
esterasesc phosphorylasesd 
erm(A), erm(B), erm(C), erm(D), erm(E), 
erm(F), erm(G), erm(H), erm(N), erm(O), 
erm(Q), erm(R), erm(S), erm(T), erm(U), 
erm(V), erm(W), erm(X), erm(Y), erm(Z), 
erm(30), erm(31), erm(33), erm(34), erm(35), 
erm(36), erm(37), erm(38), erm(39), erm(40) 
msr(A), msr(C), msr(D), 
car(A), ole(B), ole(C), 
srm(B), tlc(C), lsa(A), 
lsa(B), vga(A), vga(B), 
mef(A), lmr(A) 
ere(A), ere(B) mph(A), mph(B), 
mph(C), mph(D) 
a
 resistance to MLSB; b resistance to either lincomycin, oleandomycin, spiramycin, tylosin or streptogramin A, or both 
erythromycin and streptogramin B; c resistance to erythromycin; d resistance to macrolides (Roberts 2004). 
 
The most frequently occurring resistance mechanism towards the macrolide, lincosamide and 
streptogramin B (MLSB) antibiotics is facilitated by the rRNA methylases. These enzymes mediate 
a posttranscriptional methylation of a specific adenine residue in the 23S rRNA, which 
subsequently inhibits binding of MLSB to the 50S ribosomal subunit. Thereby the obstructing effect 
of the antibiotic is prevented. rRNA methylases can be either constitutive or inducible, but not all of 
the MLSB function equally well as inducers. Though, generally erythromycin is efficient to turn on 
the inducible genes, whereas lincomycin and streptogramin B often are not (an exception is in some 
streptococcal isolates). The inducible characteristic implies that the host will appear susceptible 
when exposed to a non-inducing MLSB antibiotic in an un-induced stated, but will assume 
resistance in an induced state (Roberts et al. 1999).  
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The majority of rRNA methylase genes was initially described in Gram-positive bacteria and also 
has a low G+C content suggestive of a Gram-positive origin or was discovered in Streptomyces spp. 
Typically, these genes are associated with mobile elements such as transposons or plasmids, which 
facilitate their dissemination. However, the host-range of the genes seems highly variable with a 
large proportion only being isolated from a single genera (for instance 1/3 of the genes are found 
exclusively in Streptomyces spp.) and another part of the genes have been discovered in a large 
number of different genera (Roberts 2004). However, the number of genera in which the individual 
genes are found seems to be increasing. Currently, the rRNA methylase gene with the widest 
distribution is erm(B), which have been found in 33 genera of both Gram-positive and Gram-
negative, aerobic and anaerobic bacteria inhabiting many different environments. A common 
coupling of erm(B) is with conjugative Tn916-like transposons in linkage with the tetracycline 
determinant tet(M) (Roberts 2004).  
The efflux genes involve ATP transporters and major facilitator transporters, which all function by 
lowering the intracellular concentration of the antibiotic via active pumping out of the cell or the 
cellular membrane. The majority of these genes, i.e. 11 out of 14 genes, are currently isolated solely 
from single genera (Streptomyces, Staphylococcus, Streptococcus or Enterococcus). In contrast, the 
most widespread of the efflux genes mef(A), which encodes resistance to erythromycin has a very 
broad host range and is found in 24 different genera (Roberts 2008). However, whether the 
difference in host spectrum relies on the association of the individual resistance genes with mobile 
elements of various range or other factors is to this point uncertain (Roberts 2004). 
Amongst the inactivating enzymes that confer resistance to macrolide antibiotics by modification of 
the drug, two esterases (Ere) and four phosphorylases (Mph) have been described. These genes 
have so far been detected in a moderately broad selection of predominantly Gram-negative bacteria. 
Though, the likelihood of identifying the genes in a more widespread number of genera is plausible, 
since relatively few studies have been attended to this area (Roberts 2004). 
 
2.4.2 Tetracyclines 
Tetracyclines inhibit protein synthesis by binding to the ribosomal 30S subunit. The binding of the 
antibiotic to the ribosome is reversible and so its bacteriostatic effect. In enteric Gram-negative 
bacteria, the tetracyclines cross the outer membrane into the periplasm via the OmpR and OmpC 
porin channels as positively charged cation-complexes. In the periplasm, the complex is believed to 
dissociate and the lipophilic tetracycline molecule can thereafter diffuse into the cytoplasm through 
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the lipid bilayer of the cytoplasmic membrane. In Gram-positive bacteria, the form of the 
tetracycline molecule that traverses the cytoplasmic membrane is also assumed to be the 
electroneutral lipophilic form. Uptake through the cytoplasmic membrane requires energy and is 
mediated by the pH gradient of the proton motive force. The environment within the cytoplasm is 
likely to enforce chelation of the tetracycline molecule and the active species that binds to the 
bacterial ribosome is assumed to be a Mg2+-tetracycline complex (Chopra and Roberts 2001). Upon 
interaction between the ribosome and the tetracycline complex a change in the secondary structure 
of the ribosome is induced. This structural rearrangement prevents the association of aminoacyl-
tRNA to the bacterial ribosome thus inhibiting elongation of the growing polypeptide by addition of 
new amino acids (Connell et al. 2003). 
Studies of bacterial populations existing prior to marketing of tetracyclines in the early 1950s have 
documented that the development of resistance towards this class of antibiotics is a phenomenon 
that have emerged in concert with introduction of the drugs (Hughes and Datta 1983). Nowadays, 
resistance is widespread in both Gram-positive and Gram-negative commensal and pathogenic 
bacteria first and forwards due to dissemination of tetracycline (tet) and oxytetracycline (otr) 
resistance determinants providing efflux- and ribosome-based resistance. Currently, 38 different 
acquired tet genes have been described of which the majority are energy-dependent efflux pumps, 
some are ribosomal protection proteins and a few code for inactivating enzymes or functions by a so 
far unknown mechanism (Table 4). The classification of genes conferring resistance to tetracyclines 
have been based on sequence homology, with genes showing more than 80% amino acid identity 
being given the same gene designation.  
 
Table 4: Mechanism of resistance for characterized tet and otr resistance genes. Adapted from (Roberts 2005).  
Efflux Ribosomal protection Enzymatic inactivation Unknown 
n = 23 n = 11 n = 3 n = 1 
tet(A), tet(B), tet(C), tet(D), tet(E), 
tet(G), tet(H), tet(J), tet(V), tet(Y), 
tet(Z), tet(30), tet(31), tet(K), tet(L), 
tetA(P)a, otr(B), tcr(3), tet(33), tet(35)b, 
tet(38), tet(39), otr(C) 
tet(M), tet(O), tet(S), 
tet(W), tet(Q), tet(T), 
otr(A), tetB(P)a, tet, 
tet(32), tet(36) 
tet(X), tet(34), tet(37) tet(U) 
a
 tetA(P) and tetB(P) are counted as one operon and tetB(P) is not found separately. 
b 
not related to other tet efflux genes 
 
The efflux genes code for energy-dependent membrane-associated proteins, which reduces the 
concentration of tetracycline within the bacterial cell by an active efflux pumping mechanism. 
Hence, protons are transferred against a gradient into the cell in exchange for tetracycline-cation 
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complexes. Of the 23 known efflux genes, three have been derived from the originally antibiotic-
producing genera Streptomyces, four genes are from Gram-positive bacteria and the latter 16 genes 
originate from Gram-negative bacteria. The efflux genes are found both in Gram-positive and 
Gram-negative bacteria and are the most prevalent found tet genes in Gram-negative bacteria 
(Roberts 2005).   
The preserving functions of the bacterial ribosomal protection proteins (RPPs) have not been 
entirely elucidated. The Tet(O) and Tet(M) are the most thoroughly studied RPPs belonging to this 
class but the other members are assumed to share similar mechanisms. A functional model has been 
proposed, where the RPPs hinder ribosomal binding of the antibiotics by interacting with the 
primary antibiotic binding site within the ribosome thus causing an allosteric disruption of the site. 
Hereby, the dissociation constant between the tetracyclines and the bacterial ribosome has been 
shown to increase significantly. However, whether the RPPs actively prevent rebinding of the 
tetracyclines after their release is unclear (Connell et al. 2003). 
It has been proposed that bacteriostatic antibiotics such as tetracycline expose a higher risk for 
development of antibiotic resistant populations. By treatment with bacteriostatic agents, the 
sensitive microbial population will be arrested in growth but not killed immediately. A large 
potential recipient population may therefore be available and transconjugants emerging will be 
favoured by the selective pressure (Licht et al. 2003). Furthermore, a specific property reported for 
tetracycline is the inducing effect on transfer frequency of the conjugative transposon family 
Tn916-Tn1545 conferring resistance to tetracycline (Showsh and Andrews, Jr. 1992). So far, this 
effect has not been described for other antibiotic resistance elements. However, in terms of risk 
assessment, this is a highly concerning property, since treatment with the antibiotic not only leads to 
selection by vertical transfer but also increases the horizontal dissemination.   
 
2.5 Resistance – intrinsic and acquired 
Intrinsic resistance (also called natural resistance) is an inherent trait that often characterizes all 
strains belonging to a given species. Oppositely, a strain that is member of a typically susceptible 
species is regarded to have acquired the resistance trait if it deviates from the normal pattern by 
showing a resistant phenotype (Normark and Normark 2002). When evaluating the risk of antibiotic 
resistance dissemination, distinguishing between intrinsic and acquired resistance is an important 
parameter (Fig. 1). Although transfer of resistance from an intrinsically resistant strain to other 
bacteria cannot be excluded, the possibility is considered minimal. Acquired resistance is either a 
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result of alteration of indigenous genes by point mutations, deletions, inversions or insertions or 
gain of exogenous genes by horizontal gene transfer (Normark and Normark 2002). The risk of 
transfer of the former can be compared to that of intrinsic resistance, whereas a high risk of transfer 
is associated with the latter, especially if the added genes are harboured on mobile elements 
(Mattila-Sandholm et al. 1999;Vankerckhoven et al. 2008).  
 
 
Fig. 1: Proposed scheme for the antibiotic resistance assessment of a bacterial strain used as a feed additive. Adapted 
from (European Commission 2005). 
 
In practice, differentiation between intrinsic and acquired resistance is not always clear-cut. First it 
must be established whether the strain is resistant or susceptible. This determination is based on the 
minimum inhibitory concentration (MIC) of the strain and the microbiological breakpoint for the 
species and antibiotic agent in question. The MIC value is the lowest concentration of the antibiotic 
that inhibits bacterial growth and several methods for MIC determination have been reported 
including the sensititre system (Floréz et al. 2005) agar dilution (Butaye et al. 2000;Floréz et al. 
2005), microbroth (D'Aimmo et al. 2007;Klein et al. 2000), E-test (Danielsen and Wind 
2003;Hummel et al. 2007) and disc diffusion (Huys et al. 2002;Perreten et al. 1998). Disc diffusion 
and E-test probably are the most widespread methods and are based on similar principles; the test 
bacterial culture is streaked onto an agar plate and growth inhibition zones adjacent to pre-
manufactured antibiotic-containing implements placed on the agar plate are measured subsequent to 
inoculation. E-test involves application of an antibiotic test strip with a built-in gradient and the 
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MIC value can be read directly from the bacterial growth zone along this gradient. In disc diffusion, 
a disc with a specific antibiotic concentration creates a diffusion gradient in the agar away from the 
disc. Measurement of the distance between the disc and the bacterial growth zone can thereafter be 
converted to a MIC value (Huys et al. 2002). Sometimes a haze or pinpoint colonies appearing 
within the inhibition zone can render the reading of MIC values difficult and subject to large 
variation depending on the examiner. A standardised protocol is an important prerequisite for the 
ability to reproduce and compare different MIC values. However, application of a single protocol 
for all species and antibiotic agents is not feasible, since optimization of growth conditions for the 
individual species and avoidance of interactions between growth media and antibiotic agent should 
be attended to. Until recently, protocols for testing of non-clinical isolates such as lactic acid 
bacteria have been in short supply. However in recent years this area have received much attention 
and although no official standard protocols have been made available so far, researchers have put a 
large effort into recommendations for formulation of such (Danielsen et al. 2004;Danielsen and 
Wind 2003;Huys et al. 2002;Vankerckhoven et al. 2008). 
Establishment of the microbiological breakpoint for a given antibiotic and species is based on the 
statistical distribution of MIC values for a whole group of strains presumed to be representative for 
that species. Ideally for establishment, the determined MIC values depict a normal distribution with 
a narrow concentration range. In this situation, the microbiological breakpoint can be set at the 
upper concentration of MICs for this cluster (Florez et al. 2007). Sometimes all strains show high 
MICs for a given antibiotic and the species is thus considered to be intrinsically resistant. Though, if 
the number of investigated strains is limited, particular notice should be given to the possibility that 
all strains tested may have received acquired resistance genes. Likewise, attention should be paid to 
the inability of this phenotypic method to detect acquired resistance genes in a background of 
intrinsic resistance. On the contrary, if a microbiological breakpoint is set and outliers with MICs 
above this breakpoint concentration are pointed out, the strains can be considered to have acquired 
resistance. In the light of a risk evaluation, these strains should be subject to further analysis in 
order to establish the genetic basis for resistance (European Commission 2005;Florez et al. 
2007;Kastner et al. 2006;Vankerckhoven et al. 2008).  
 
2.6 Antibiotic resistance in Lactobacillus spp. 
In recent years, several investigations have been undertaken in order to elucidate the occurrence of 
antibiotic resistance in lactobacilli. These investigations have been hampered by the lack of 
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standardised methods for MIC testing, lack of well-founded microbiological breakpoint values and 
large species variation in antibiotic resistance phenotypes. Therefore a process was initiated in order 
to create a basis for distinguishing susceptible strains from strains with intrinsic resistance or 
acquired and thus putative transferable resistance (Danielsen et al. 2004;Danielsen and Wind 
2003;Huys et al. 2002). A good fundament has now been established, but there is still call for 
optimization of methods and adjustment of microbiological breakpoint values as more strains are 
being tested (Ammor et al. 2007;Vankerckhoven et al. 2008). 
Generally, lactobacilli have been reported to be intrinsically resistant to the folic acid metabolism 
inhibitors trimethoprim and sulphonamides. Folic acid is used e.g. for the synthesis of purines, 
which is required as an external supplement for many lactobacilli to be able to grow. Lack of the 
folic acid synthesis pathway and thus the target for trimethoprim and sulphonamides has therefore 
been suggested as the cause of resistance (Katla et al. 2001). Dihydrofolate reductase (DHFR) is the 
specific target for trimethoprim and is responsible for the last step in the folic acid pathway 
converting dihydrofolate to the active tetrahydrofolate. An early study has shown that some 
lactobacilli contain DHFRs that are insensitive to trimethoprim and proposed this quality to be 
connected with resistance (Then and Riggenbach 1978). This finding is in correspondence with a 
recent Danish study, which tested the effect of bacterial growth medium composition on 
trimethoprim susceptibility (Danielsen et al. 2004). Here it was stated that lactobacilli do not have 
intrinsic resistance to trimethoprim. Rather, the presence of thymidine in MRS medium commonly 
used for MIC testing was suggested to be the cause of erroneous conclusions on intrinsic resistance. 
Thymidine antagonizes the action of trimethoprim but was excluded from the medium in the 
experiments performed by Then and Riggenbach, thus making their results more reliable. 
Resistance to the cell wall inhibiting glycopeptide, vancomycin is widespread among lactobacilli. In 
this case lack of the vancomycin target D-Ala-D-Ala dipeptide is responsible, since most 
Lactobacillus species contain D-Ala-D-Lactate in the peptidoglycan layer instead, thus providing 
intrinsic resistance (Ammor et al. 2007). Other inhibitors of the cell wall synthesis such as β-
lactamase inhibitors and the penicillins piperacillin and ampicillin are normally active against 
lactobacilli whereas higher resistances are observed toward oxacillin and cephalosporins and large 
variation exists in the resistance profiles of different Lactobacillus species to bacitracin. Resistance 
to cell wall synthesis inhibitors is mainly caused by impermeability of the cell wall due to the 
absence of cytochrome-mediated electron transport. Contributing to the different resistant patterns 
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between species are however also multidrug transporters and defective cell wall autolytic systems 
(Ammor et al. 2007).  
Altogether, lactobacilli are susceptible to antibiotics inhibiting the synthesis of proteins such as 
tetracycline, erythromycin, clindamycin and chloramphenicol, whereas higher tolerance towards 
aminoglycosides such as neomycin, kanamycin, streptomycin and gentamicin largely seems to be 
an inherited characteristic (Ammor et al. 2007;Hummel et al. 2007).  
The frequency of Lactobacillus strains, which deviates considerably from the normal susceptible 
population, is usually low. Amongst a selection of 45 LAB probiotic or starter strains (including 17 
Lactobacillus strains) analysed for various antibiotic resistances, Hummel and coworkers reported 
only one non-wild-type isolate, which harboured the erm(B) gene conferring resistance to 
erythromycin (Hummel et al. 2007). Likewise, a study of 189 Norwegian LAB starter strains of 
which 55 were different species of Lactobacillus, reported only one isolate to be resistant. This 
isolate showed high-level streptomycin resistance, but the genetic basis for the resistance was not 
investigated (Katla et al. 2001). In another extensive examination of antibiotic resistance in 473 
LAB strains predominated by lactobacilli and including probiotic and starter strains, 0.8% of the 
strains exhibited phenotypic resistance to streptomycin, erythromycin or clindamycin and 3.1% 
were resistant to oxytetracycline. Isolates with MICs exceeding the microbiological breakpoint 
values were further subjected to PCR analysis for detection of known resistance genes. No 
streptomycin resistance genes were detected but in some of the isolates tet(W), tet(M) or erm(B) 
were found, presumably explaining the observed resistances (Klare et al. 2007). Similarly, a study 
including 74 Lactobacillus strains from Swiss starter and probiotic cultures examined 
phenotypically deviating isolates for resistance genes by microarray hybridization. The presence of 
tet(W) and lnu(A) conferring resistance to tetracycline and lincosamide, respectively, was 
confirmed in one L. reuteri isolate and the latter determinant was found to be associated with a 
plasmid. 
Antibiotic resistant Lactobacillus strains have also been isolated from a range of different food 
products such as fermented drinks and yoghurts (D'Aimmo et al. 2007;Temmerman et al. 2003), 
cheese (Catatolok and Gogebakan 2004;Florez et al. 2005), fermented sausages (Gevers et al. 2000) 
and raw and processed pork and chicken meat products (Aquilanti et al. 2007). Different studies 
have also looked at resistance in lactobacilli originating from human samples, and both relatively 
low incidences (Charteris et al. 1998) and extraordinary high incidences of resistances have been 
reported (Catatolok and Gogebakan 2004). 
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Many different types of antibiotic resistance determinants have been detected in lactobacilli, for 
instance the chloramphenicol resistance gene cat, the aminoglycoside resistance gene aph and 
several different genes conferring resistance to erythromycin mef(A) and the MLSB antibiotics erm- 
(B, C, G, F, T) or tetracycline tet-(K, M, O, Q, S, W, L, Z, 36). The most frequently occurring 
determinants, however, seem to be erm(B) and tet(M) (Ammor et al. 2007;Aquilanti et al. 
2007;Catatolok and Gogebakan 2004;Roberts 2008).  
Overall, the number of studies, which have investigated transferability of native antibiotic resistance 
determinants from lactobacilli, is limited. A Belgian study confirmed conjugation of tetracycline 
and erythromycin resistance plasmids from a range of different Lactobacillus species to E. faecalis 
and L. lactis recipients by in vitro filter mating (Gevers et al. 2003b), but most of the performed 
studies have failed to detect transferability (Hummel et al. 2007;Kastner et al. 2006;Klare et al. 
2007). Negative transfer results are however not unequivocal proof of immobility of these 
determinants and in general more analyses are required to shed light on the mobility of acquired 
antibiotic resistance determinants in Lactobacillus. 
  
3. Gene transfer 
Gene transfer is a very important means of bacterial adaptation to changing environments. 
Generally three major mechanisms of horizontal gene transfer (HGT) between bacteria exist: 
transformation, transduction and conjugation. Transformation was the first mechanism of HGT to 
be discovered. The process involves active uptake of DNA released from the surroundings and 
subsequent integration and replication in the new host. In order to accomplish the first step 
concerning uptake of free DNA into the cell, the bacteria need to be competent. Amongst bacteria 
analysed for natural competence, approximately 1-2%, including both Gram-positive and Gram-
negative bacteria has been shown to possess this ability (Jonas et al. 2001;Thomas and Nielsen 
2005). In as far as the free DNA is comprised of chromosomal genetic material, incorporation by 
homologue recombination in the new host is necessary. This step usually confines transformation to 
closely related species (Thomas and Nielsen 2005). During the last decade, increased marketing of 
products containing genetically modified organisms (GMOs) has attracted attention to the risk of 
transformation of genetic material in the mammalian gut. However, experiments dealing with this 
topic have found no indications of transformation of genetically modified plant DNA to bacteria in 
an intestinal environment (van den Eede et al. 2004).  
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Transduction is the process of HGT mediated by bacteriophages, which are bacterial viruses. Some 
bacteriophages can during the lytic cycle incorporate parts of the host DNA into their capsid by 
accident. Upon lysis of the host cell these so-called transducing and usually virally defective 
particles are released and can be reinjected into new host cells. The injected donor genes must 
hereafter be incorporated by homologous recombination into the recipient in order to be maintained 
– a process known as generalized transduction (Madigan et al. 1997). A second mechanism is 
known as specialized transduction and involves the accidental incorporation of host DNA directly 
into the genome of a temperate bacteriophage. In contrast to the virulent bacteriophage, which only 
option is to follow the lytic pathway, the temperate bacteriophage can choose a more passive 
pathway entering a lysogenic circle in the host. This implies another possibility than homologous 
recombination for maintenance of the host DNA – namely the integration of the modified 
bacteriophage genome into the host chromosome and simultaneous replication as a prophage 
(Madigan et al. 1997). In more seldom instances, the genome of the bacteriophage may also 
replicate independently in the host as a circular or linear plasmid (Frost et al. 2005).  
Investigations of the extent of HGT by transduction in the GI tract are scarce, though some studies 
have reported that transduction in this environment can take place (Acheson et al. 1998;Cornick et 
al. 2006). The narrow host-range of most bacteriophages implies that dissemination by this 
mechanism mostly occurs among bacteria of close relation. However, compilation of data from 
recent years sequencing projects has revealed extensive mosaicism in bacteriophage genomes. This 
finding has led to a reassessment of the significance of transduction. Hence the widespread 
distribution of bacteriophages combined with their extensive numbers may increase the chance of 
both homologous and non-homologous successful recombination, thus providing a larger input to 
bacterial plasticity than previously anticipated (Hendrix 2003). 
Conjugation is the third mechanism of HGT and is still regarded as the most important contributor 
to bacterial gene shuffling. Conjugation has potential to occur at a very high rate and between 
phylogenetically very distinct bacteria - even inter-kingdom transfer has been reported. In contrast 
to transformation and transduction, a prerequisite for conjugal transfer is intimate contact between 
donor and recipient bacteria. In Gram-negative bacteria, the mechanism for establishment of cell-to-
cell contact is well known and shown to take place via complex extracellular filaments named sex 
pili. In contrast, the corresponding establishment of physical contact between Gram-positive 
bacteria is more elusive (Grohmann et al. 2003). The mediator of this establishment are the so-
called transfer (tra) genes that can be harboured either on large conjugative plasmids (>20 kb), 
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conjugative transposons or on the chromosome. Transposons are mobile elements, which are devoid 
of an autonomous replication machinery and therefore depend on the integration and replication in 
conjunction with the chromosome or a plasmid. Transposons contribute significantly to the spread 
of antibiotic resistance genes however, in this Ph.D-project focus has been on conjugation mediated 
by plasmids, therefore the following paragraph will be subjected to this field.  
 
3.1 Plasmids 
Plasmids are extrachromosomal and usually circular elements of DNA that contain their own genes 
for initiation and control of replication. The plasmids replicate autonomously within the host 
bacterium, but several steps in replication rely on host-encoded factors, making the compatibility 
between the plasmid and the host essential for maintenance of the plasmid. On the other hand, 
plasmids are not essential to the host. In fact some small plasmids are cryptic i.e. they have no 
assigned function besides their own maintenance. However, plasmids often contain genes coding 
for trades that can be advantageous or even essential for survival in certain environments such as 
resistance to antibiotics, phages and heavy metals, bacteriocin production, metabolism of 
carbohydrates etc. (Pouwels and Leer 1993;Wang and Lee 1997).  
In lactobacilli native plasmids are prevalent. At least 25 different species of lactobacilli have been 
shown to harbour natural resident plasmids and multiple plasmids (usually from 1-10) have 
commonly been identified in a single strain (Wang and Lee 1997). Most plasmids in lactobacilli are 
small (<10 kb) cryptic plasmids, however, larger plasmids of more than 100 kb have also been 
detected (Pouwels and Leer 1993;Wang and Lee 1997).  
 
3.2 Plasmid transfer by conjugation 
Transmissible plasmids can be either conjugative meaning that they encode a self-sufficient transfer 
system or mobilizable implying a requirement for supplementary conjugative genes to accomplish 
transfer (Francia et al. 2004). Mobilizable plasmids commonly harbour a mobilization region, 
which contain genes necessary for relaxation of the DNA (mob) and an origin of transfer (oriT). In 
contrast to conjugative plasmids, mobilizable plasmids lack (tra) genes responsible for creation of 
mating-pair formation (Francia et al. 2004). Transfer of mobilizable plasmids is therefore dependent 
on the presence of tra genes as described above. If transfer is mediated by another conjugative 
(helper) plasmid, the mobilizable plasmid may either be co-transferred with the helper plasmid 
(conduction) or transferred alone to the recipient (donation). The further dissemination of the 
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mobilizable plasmid from the new host may therefore be restricted if no operational tra genes are 
available in the new host.  
Plasmid DNA relaxases are thought to be evolutionary related amongst most transferable plasmids 
and the phylogenetic relatedness has been used as a criterion for classification into different 
relaxase families and small mobilizable plasmid families (Francia et al. 2004;Grohmann et al. 
2003). The plasmid relaxases are key components required to prepare the DNA for transfer. By 
binding to the supercoiled plasmid DNA and catalysation of a transesterification reaction, the DNA 
is nicked in a strand-specific manner at oriT. The resulting product is a cleaved double-stranded 
DNA molecule with a free 3’-OH end and the relaxase covalently bound to the 5’ end of the strand 
via a phosphodiester bond (Fig. 2). In order to produce the single strand of plasmid DNA that can 
be transferred to the recipient, the interaction of a DNA helicase to unwind the intermediate DNA 
molecule is required. The helicase activity is incorporated in some plasmid relaxases, however in 
others the source of activity has not been established (Byrd and Matson 1997).  
 
Fig. 2: Activity of a DNA relaxase. Nicking of supercoiled plasmid DNA at oriT by attack of the active tyrosine residue 
and covalent binding of the relaxase to the 5’end of the cleaved DNA. Adapted from (Byrd and Matson 1997). 
 
The relaxase enzymes contain three conserved motifs forming part of the catalytic centre. Motifs I 
and III have been universally found in relaxases of both conjugative and mobilizable plasmid 
origin. Motif I contains the active tyrosine residue, which is involved in the nucleophilic attack and 
nicking at oriT and motif III (characterized by two conserved histidine residues) has been proposed 
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to support the attack by the active tyrosine residue by binding of the Mg2+ or Mn2+ cation required 
for the cleavage reaction (Grohmann et al. 2003).  
In contrast to mob and tra genes, which can be provided in trans, the only element required in cis 
for a plasmid to be transferable is the oriT. However, different families of oriT exist and successful 
transfer is dependent on the ability of the relaxase to recognize oriT but also on compatibility 
between the mob and tra genes (Grohmann et al. 2003). 
 
3.3 Mechanisms of replication  
The two major mechanisms of plasmid replication are the theta type replication and rolling-circle 
replication (RCR). The theta mechanism is so named due to the characteristic theta shape that 
coupling between the newly synthesized and the parental plasmid strands assume during replication. 
Replication is initiated at either one or several origins by dispersion of the parental strands followed 
by synthesis of a primer RNA, which is covalently extended by DNA polymerase. The leading- and 
lagging-strand are synthesized simultaneously and can be either in the same direction or in opposite 
directions, but whereas replication of the leading strand is continuous synthesis of the lagging 
strand are discontinuous, requiring the synthesis of primer RNAs at regular intervals (del Solar et al. 
1998). Theta replication is prevalent amongst larger Gram-positive plasmids such as those 
belonging to the pAMβ1 family of plasmids isolated from various enterococci and streptococci 
(Bruand et al. 1993). However, in small Gram-positive plasmids, the general mode of replication is 
RCR. Since focus during this Ph.D-project primarily has been on plasmids replicating via RCR, the 
following paragraph will be devoted to this mechanism.  
Initially, the mechanism was identified in a number of small (< 10 kb), multicopy plasmids from 
Gram-positive bacteria and indeed most RCR plasmids belong to this category. However later, RCR 
has also been detected amongst plasmids of Gram-negative origin (Actis et al. 1999). At least 
fourteen families of bacterial RCR plasmids have been classified according to homology in factors 
crucial for their replication namely the replication initiator (Rep) protein and the origin of 
replication (ori) also denoted the double-strand origin (dso) (Ilyina and Koonin 1992;Khan 
1997;Osborn 2008). Most RCR plasmids from Lactobacillus, however seem to belong to RCR 
group II or III (Table 5), having the RCR plasmids pMV158 originating from Streptococcus and 
pC194 originating from Staphylococcus, respectively, as prototypes (Khan 1997). 
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Table 5: Sequenced RCR plasmids from Lactobacillus divided into RCR groups according to similarities in Rep 
proteins according to (Osborn 2008). Special features concerning antibiotic resistance genes or mobilization (mob) 
genes are listed when found. 
Name  Size 
(bp) 
Host species RCR 
group 
Special 
features  
Accession No. (Reference) 
PLFE1 4031 L. plantarum II mob1/erm This study 
pLC2 2489 L. curvatus II  Z14234 (Klein et al. 1993) 
pA1 2820 L. plantarum II mob2 Z11717 (Vujcic and Topisirovic 
1993) 
pLA106 2862 L. acidophilus II mob D88438 (Sano et al. 1997) 
pLB4 3547 L. plantarum II  M33531 (Bates and Gilbert 1989) 
pLF1311 2389 L. fermentum II  X74860 (Aleshin et al. 1999) 
pLH2 5727 L. helveticus II  X81981 (Pridmore et al. 1994) 
ppsc22*   L. plantarum II  X95843 (Cocconcelli et al. 1996) 
pLEM5** 3382 L. fermentum III erm U48430 (Fons et al. 1997)  
pC30il 2140 L. plantarum III  JO3319 (Skaugen 1989) 
pGT232 5113 L. reuteri III  U21859 (Heng et al. 1999) 
pLAB1000 3331 L. hilgardii III mob M55222 (Josson et al. 1990) 
pLC88 3501 L. casei III mob U31333 (not published) 
P353-2 2425 L. pentosus III  X62347 (Leer et al. 1992) 
pLP1 2093 L. plantarum III  M31223 (Bouia et al. 1989) 
pLTK2 2295 L. plantarum III  AB024514 (Kaneko et al. 2000) 
pTC82***  L. reuteri III cat-TC AF183511 (Lin et al. 1996;Lin et 
al. 2001) 
*vector derived from a 7 kb plasmid (only the replication region has been sequenced). **vector derived from a 5.7 kb 
plasmid, pLEM3. ***Only the replication region and the antibiotic resistance gene have been sequenced from plasmid 
pTC82. 1Putative truncated mob gene - no expression observed. 2Putative truncated mob gene, presumably encoding a 
non-functional protein.  Erm, erythromycin resistance gene; cat-TC, chloramphenicol acetyltransferase.   
 
The RCR plasmids have a common mode of replication (Fig. 3), although variations in the 
individual steps may exist. In general, replication is initiated by interaction between the Rep protein 
and its cognate dso. This interaction results in a structural rearrangement of the dso region, which 
commonly exposes the nick site within the loop of a hairpin structure (Fig. 3B) (Khan 1997). 
Hereafter, the Rep protein cleaves the leading strand at the nick site and binds covalently to the 5’ 
phosphate end of the DNA. A 3’ OH end is thereby left free to function as a primer for replication 
of the new leading-strand (Fig. 3C). The next extension step involves several host proteins 
including DNA helicase that unwinds the double-stranded plasmid DNA making it accessible for 
replication by DNA polymerase III. The polymerase extends the replication fork unidirectionally, 
synthesizing a new leading strand and simultaneously replacing the parental leading strand, which 
subsequently are coated by the single-stranded DNA binding (SSB) protein (Fig. 3D). Upon 
accomplishment of one circle, i.e. approximately 10 nucleotides beyond the regenerated dso nick 
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site, the synthesis is terminated by the second monomer of the Rep protein, which nicks and thus 
releases the displaced strand. The result of one round of replication is a double-stranded DNA 
molecule constituted by the parental lagging-strand and the newly synthesised leading-strand and a 
single-strand intermediate consisting of the parental leading-strand (Fig. 3E).  
The Rep protein normally supports only one round of plasmid replication, which is important for 
regulation of the plasmid replication. Cessation of replication often occurs by inactivation of the 
Rep protein through attachment of an oligonucleotide (approximately 10bp) to its active tyrosine 
residue. This oligonucleotide corresponds to the sequence immediately downstream of the nick site 
(Fig. 3F) (Khan 1997;Khan 2005).  
 
 
Fig. 3: Model for replication of rolling-circle plasmids. SC, supercoiled; SS, single-stranded; PcrA Helicase, Gram-
positive helicase. Adapted from (Khan 2005). 
 
All RCR plasmid families replicate through production of single-strand intermediates and detection 
of single-stranded DNA have therefore commonly been used as verification of the RCR mechanism 
(Josson et al. 1990;Leer et al. 1992;Vujcic and Topisirovic 1993;Wu et al. 2007). However, 
completion of plasmid duplication requires conversion of the single-strand intermediate into 
double-stranded DNA. The single-strand origin (sso) is the starting point of lagging-strand synthesis 
and lack of a functional sso has been shown to result in accumulation of single-stranded DNA (Leer 
et al. 1992;van der Lelie et al. 1989) and thus segregational instability of the plasmid (Gruss and 
Ehrlich 1989). The presence of several functional ssos on a plasmid is possible (van der Lelie et al. 
   A 
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1989) but in most cases a single sso is placed immediately upstream the dso. Upon completion of 
the leading-strand synthesis, the sso is present in a single-stranded form and the sso promoter 
sequence can be recognized by host RNA polymerase. Hereby a short primer RNA is synthesized 
and used by DNA polymerase to initiate replication of the lagging strand using the leading-strand as 
a template (Fig. 3G) (Kramer et al. 1999).  
 
3.4 Copy number control 
Plasmids can range in copy number from one to several hundred per cell, but for a given plasmid 
replicating under constant conditions, the copy number is relatively invariable. Partitioning systems 
control the equal distribution of plasmid copies from the mother cell to the two daughter cells. In 
plasmids that are only present in one or a few copies, an effective partitioning system is very 
important to ensure that all dividing cells receive the plasmid. In contrast, multicopy plasmids does 
not always require such a system, since by chance the risk of a daughter cell receiving no copies is 
somewhat smaller (Novick 1987). As a consequence, RCR plasmids typically do not contain 
partitioning systems but instead control copy number by regulation of replication (Rasooly and 
Rasooly 1997).  
Control of plasmid replication is a critical point in maintaining copy number. In general, two types 
of control systems exist for replication. One mechanism is based on repeated DNA sequences (i.e. 
iterons) located at different sites of the plasmid (Actis et al. 1999). Several mechanisms act in 
concert to control the copy number in iteron-based regulation. The active Rep protein concentration 
is limited in several ways, e.g. by binding of the protein to iterons. However, the limitation of active 
Rep protein only works as a buffer, but is not sufficient to control fluctuations in plasmid copy 
number. The most important regulator in this system is inactivation of the origin of replication (ori). 
A package of iterons is positioned adjacent to or overlapping with ori. If the plasmid copy number 
is increased above the normal level or if another plasmid harbouring the same replication control is 
introduced into the same host, the elevated plasmid concentration will be counterbalanced by 
increased pairing of iterons belonging to separate oris. This pairing is believed to cause a steric 
hindrance to their function (Paulsson and Chattoraj 2006).  
The other basic control mechanism in plasmids relies on small complementary RNA molecules 
known as antisense or countertranscript (ct) RNAs. These molecules act either by hybridizing to a 
plasmid-determined target that inhibits replication directly or they act indirectly by hindering 
synthesis of the Rep protein (Actis et al. 1999).  
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In contrast to the iteron-based system, the limitation of Rep protein achieved in this way is 
sufficient to control the plasmid copy number. However, in some plasmids such as RCR plasmids 
belonging to the pMV158 family, ctRNAs acts in concert with proteins to control plasmid 
replication (del Solar and Espinosa 1992). In the pMV158 derivative plasmid pLS1, synthesis of the 
replication initiation protein RepB is controlled both by a small 50-nucleotide long ctRNA and 
CopG (previously denoted RepA) (Fig. 4). ctRNA is transcribed from promoter Pct in the opposite 
direction of the bicistronic mRNA encoding CopG and RepB. ctRNA is believed to control 
synthesis of RepB at the translational level by pairing with a region of the copG-repB mRNA 
including the RBS of repB and thus inhibit binding of the ribosomes (del Solar et al. 1997). CopG 
exerts its controlling effect by binding to a region encompassing the –35 promoter box of the single 
promoter Pcr, responsible for transcription of the operon containing copG itself as well as repB. 
Hence, CopG acts as a transcriptional repressor protein preventing binding of host RNA polymerase 
and thus synthesis of copG-repB mRNA (del Solar et al. 2002). 
 
 
 
Pct 
RBS 
 
Fig. 4: Copy control regulation in pLS1. RepB exerts a positive effect by initiating replication of pLS1. CopG and 
ctRNA are negative regulators of RepB (see text for details). Modified from (Rasooly and Rasooly 1997) in accordance 
with (del Solar and Espinosa 1992). 
 
 
 34
3.5 Plasmid incompatibility  
Plasmid incompatibility is when two plasmids fail to be stably maintained in the same host in the 
absence of selective pressure. This phenomenon is the result of plasmids harbouring similar 
functions for inheritance such as partition or replication (Novick 1987). As these functions are very 
fundamental for the plasmid, classing the plasmids into incompatibility groups is used as a measure 
of relatedness, with plasmids belonging to the same group sharing common features (Actis et al. 
1999). The traditional method of incompatibility grouping relies on the simple observation of 
elimination or coexistence between different plasmids transformed into the same cell line. However, 
a single base change in specific regions covering these functions can render two otherwise 
incompatible plasmids compatible (Couturier et al. 1988). Therefore, this method can potentially 
place two plasmids into different incompatibility groups despite a remarkable degree of affiliation. 
In contrast, two plasmids may be assigned to different incompatibility groups although they share 
similar replication functions. Hence, if one of the plasmids carry more than one region of 
replication it may avoid segregation by switching to control by the compatible mechanism and 
thereby conceal the presence of the former (Couturier et al. 1988). Concurrently with the improved 
accessibility to DNA sequencing data, a more comprehensive and rapid classification scheme has 
been made based on similarity of replication (rep) region DNA sequences. Classification of 
plasmids using this criteria can be made with variable accuracy depending on the choice of method 
e.g. sequence analysis or hybridization using more or less degenerated probes and stringency 
conditions (Couturier et al. 1988).  
 
 
3.6 Host-range 
The host range of plasmids is highly variable with some plasmids only replicating in hosts 
belonging to a few species thus exercising a narrow host-range and other plasmids showing a broad 
host-range proliferating in a variety of different genera or even across kingdoms. The majority of 
plasmids are however confined to either Gram-positive or Gram-negative bacteria (Courvalin 
1994).  
Many traits are decisive of the host-range of a conjugative or mobilizable plasmid and for a given 
plasmid the specific factors are often poorly understood. Inheritance of a plasmid in a new host 
requires successful accomplishment of two principal steps; first the transfer process itself should be 
possible and subsequently, stable replication in the recipient must occur. The former step is 
generally regarded as less prohibitive and the latter step rate-limiting (del Solar et al. 1996).  
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The key component responsible for establishment of the plasmid in the host is the replicon, which 
can be more or less autonomous but often must comply with certain host factors to accomplish 
replication. In the laboratory, fusions of replicons functional in different hosts are used to increase 
the diversity of hosts fitted for a given plasmid. However, in nature this strategy does not seem 
feasible and several plasmids containing multiple replicons though exhibiting a narrow host-range 
have been described (del Solar et al. 1996).  
The host-range of RCR plasmids also extents from narrow to extremely broad. An example of the 
latter is the mobilizable plasmid pIP823 from L. monocytogenes. Mobilization of pIP823 has been 
reported to occur by the aid of self-transferable conjugative plasmids to strains of E. faecalis, S. 
aureus, B. subtilis and E. coli (Charpentier et al. 1999). In RCR plasmids, synthesis of the leading 
strand is independent of host proteins, but initiation of lagging strand replication requires 
recognition of the sso by host RNA polymerase. Four types of ssos have been described in the 
litterature namely ssoA, ssoT, ssoU and ssoW. Most of the ssos function only optimally in their 
natural hosts, however the ssoU has the quality that it can be efficiently recognized in a broad range 
of Gram-positive bacteria such as Bacillus subtilis, Staphylococcus aureus, Streptococcus 
pneumoniae and Lactococcus lactis. The ability of the host RNA polymerase to bind efficiently to 
the promoter sequences of the sso has been proposed to be an important determinant of the host-
range of the plasmid (Kramer et al. 1999). 
In the pheromone-inducible plasmids, which are present in E. faecalis, release of pheromones 
trigger bacterial clumping and thus promote cell-to-cell contact (Dunny et al. 1995). However, in 
most other cases, the factors controlling establishment of cell-to-cell contact between potential 
donor and recipient bacteria remain cryptic. An aspect that influences the success of mating-pair 
formation is the interaction between the pilus/pore junction and the lipopolysaccharides and surface 
membrane proteins of the recipient cell (Thomas and Nielsen 2005). In this regard, the cell wall of 
Gram-positive bacteria has been suggested to constitute an important barrier to transfer of DNA 
from E. coli (Courvalin 1994). Though, speaking in favour of a relatively unrestrictive transfer 
barrier between Gram-negative and Gram-positive bacteria, a recent study showed dissemination of 
an IncP-1 plasmid from Pseudomonas putida to a broad range of recipients including a Gram-
positive member of the Actinobacteria (Musovic et al. 2006). However, the collection of 
transconjugants was performed in a cultivation-independent manner. Thus the study merely verified 
the ability of the plasmid to be transferred to, but not maintained in the recipient bacteria.  
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Another factor that may affect the dissemination probabilities of a given plasmid is the host in 
which it resides. A study evaluating the diversity of transconjugants receiving the IncP-1β plasmid 
pB10 showed a significant difference depending on the donor, when the plasmid was mated to the 
same population of sludge bacteria (De et al. 2005). Obviously, this finding is not a matter of 
divergence in integration or replication potential of the plasmid in the various recipients but sooner 
a result of attachment and establishment of well-functioning mating channels between different 
mating pairs. A side-issue to this is also the environmental preferences of certain bacteria. Hence 
some bacteria may be more prone to occupy a distinct niche (for instance in the GI tract) and thus 
encounter another variety of potential recipients than the donor residing in a different niche. All in 
all, a plasmid may be disseminated in promiscuous ways and a seemingly “dead-end” of transfer, 
may be overcome by movement to a new host, facilitating the apparently insuperable move.   
 
 
4. Models of the human gastrointestinal tract 
4.1 Factors affecting transfer in the gastrointestinal tract  
An intimate contact between the donor and recipient bacteria, is as earlier mentioned a prerequisite 
for exchange of antibiotic resistance genes by conjugation. In the GI tract, the density of bacteria 
increases from the small intestine consisting of duodenum, jejunum and ileum and downwards to 
the caecum, which is placed as a blind pocket at the connection between the small and large 
intestine, to the colon, comprising the large intestine (Fig. 5). A relatively low concentration of 
approximately 103-104 cfu/g is present in duodenum, constituting the upper part of the small 
intestine whereas in the colon an exceptionally high concentration of 1011-1012 cfu/g of intestinal 
contents is found. In the colon, bacterial mass has been estimated to account for up to half of the 
volume content (Isolauri et al. 2004). This large density of bacteria means a great potential to 
encounter recipients and establish cell-to-cell contact.  
The GI tract contains from 300 to 500 different bacterial species that may be either transiently 
present or comprise a part of the indigenous microbiota (Guarner and Malagelada 2003). The 
bacteria are not equally distributed throughout the intestine since environmental conditions differ 
between the intestinal compartments, but also within small-scale distances of compartments (such 
as between the mucus layer and lumen content), conditions and thus bacterial compositions are 
varying (Anderson 2003). In the small intestine, Lactobacillus counts for a significantly large 
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proportion of bacteria, as is shown in Fig. 5, depicting the numerically dominant genera in each 
intestinal compartment.    
 
 
Fig. 5: Bacterial density and composition of numerically dominant genera in the adult human GI tract. Adapted from 
(Isolauri et al. 2004) 
 
When a bacterium enters the GI tract via food etc., it encounters a very hostile environment with 
acidity as low as pH 2 in the stomach and bile acids excreted in the small intestine. Furthermore, 
release of inhibiting factors from other bacteria and competition for nutrients and available space 
(i.e. the colonization resistance of the indigenous microbiota) may affect the physiological status of 
the ingested bacteria. In order to colonize the GI tract, these obstacles have to be overcome by 
growth and/or binding to intestinal surfaces at an efficiency that counteracts the peristaltic 
movements of the intestine. In this regard, bacterial ability to initiate mating-pair formation has 
been suggested to influence their survivability. Apart from the obvious potential in adaptability by 
accepting genetic elements, also attachment to intestinal epithelial cells and surface structures has 
been proposed as a benefit of the conjugation system. In some cases the presence of pili or surface 
aggregation substances that are required for conjugation, may enable bacteria to hold on to 
intestinal surfaces or to each other, thus promoting colonization (Licht and Wilcks 2005).   
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Although the physiological status of the donor and recipient bacteria influences their ability to 
transfer and receive plasmids, colonization of the gut is not a prerequisite for transfer of antibiotic 
resistance genes. Hence, several studies have reported transfer from a donor, which was only 
transiently passing the intestine (Gruzza et al. 1994;Licht et al. 2002;Schlundt et al. 1994). Yet, 
colonization may increase the chance of mating events in the intestine both due to proliferation and 
potentially higher numbers of the donor, but also to increase of the time span in which potential 
contacts may take place. The latter may especially be important upon interruptions of environmental 
conditions in the GI tract, for instance imposed by antibiotic treatment.   
 
4.2 In vitro mating 
In vitro mating is the most common method to investigate the conjugation ability of specific donor 
and recipient bacteria and an easy way to transfer specific desirable mobile plasmids to new 
recipients. This method traditionally involves separate culturing of the test bacteria followed by 
mixing in broth media or on agar plates (with or without filters). The mixture are incubated for a 
given period allowing the mating process to occur and thereafter harvesting and plating on selective 
media for both the recipient, donor and transconjugant bacteria are performed. This method is 
cheap, easy and fast compared to in vivo experiments and allows the conjugation to proceed under 
controlled conditions. The mating procedure can be optimized to offer the best conditions for 
transfer and the impact of specific factors on transfer frequency can be analysed. Furthermore, the 
transfer potential of different mobile elements and mating-pairs can be compared under similar 
conditions.  
A draw-back of the method is absence of standardization and thus comparability between different 
published experiments, and also lack of knowledge about conditions optimal for transfer. Several 
factors affect transfer, amongst others the growth rate and induction of different stress response 
mechanisms of the donor and recipient bacteria (Mcmahon et al. 2007). Likewise, the phase of the 
mating medium e.g. if it is solid or liquid (Wilcks et al. 2005) and the structure of the mating 
surface, which can be prepared in vitro with filters of different pore sizes (Gevers et al. 
2003b;Sasaki et al. 1988), have been shown to change transfer frequencies or reverse positive or 
negative outcomes. However, the optimal transfer conditions for a given mobile element and 
mating-pair may not necessarily be ubiquitous for all mating-pairs and even opposite effects 
achieved by regulation of a specific factor may occur.  
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In conclusion, in vitro mating can be used to assess if a specific genetic element have the potential 
to be transferred. However, negative conjugation results in vitro do not justify rejection of the 
possibility that transfer can take place under different circumstances in vivo. Furthermore, the 
effectiveness of in vivo transfer for a given mobile element and mating-pair is difficult to predict by 
in vitro analyses. In contrast to in vivo studies, in vitro mating enables calculation of the number of 
transfer events. In the intestinal environment this calculation is severely biased by growth of the 
bacteria and thus vertical transfer of the mobile element. Several studies have reported that the in 
vivo transfer potential deviated considerably from the predicted potential based on in vitro mating 
frequencies (Dahl et al. 2007;Netherwood et al. 1999).  
 
4.3 Germ-free/di-associated rats 
In this project germ-free rats have been used as an in vivo model for the human GI tract. This model 
constitutes a relatively controlled approach to evaluate the ecology of bacteria during physical 
influences resembling those encountered in human. A remarkable advantage of germ-free rats is the 
ability to possess full control of bacteria added to the “test system”. However, in contrast to human, 
the rat is coprophagues meaning that it ingests faeces. When investigating bacterial interactions 
with this model, practical measures such as gratings and individual cages therefore need to be 
considered in order to prevent “re-inoculation” of the rats.  
Basically, the GI system of the rat and human is similar, nevertheless variations in gut physiology, 
pH, peristalsis, secretions etc. may result in different bacteria being promoted in the two hosts 
(Rumney and Rowland 1992). The same applies to differences in the food/feed. Though, if this is 
considered important for a particular experiment, a specific diet can be prepared to the test animals. 
Ethical considerations obviously need to be taken when planning experiments with research animals 
such as germ-free rats. Whenever possible in vitro methods should replace animal experiments yet, 
if the alternative is experiments conducted with human volunteers subjected to an increased risk, 
germ-free rats may be preferred. 
Germ-free rats allow for determination of the gene transfer potential of specific donor-recipient 
pairs without competition and interference from other intestinal bacteria. By di-association i.e. 
inoculation with only two different strains of bacteria, a much higher concentration of the particular 
bacteria is achieved than would be the case in a normal intestine harbouring a complex intestinal 
microbiota conferring colonization resistance. The bacteria are to a high degree exposed to the same 
factors as they are during passage of a normal GI tract however, their higher concentration increases 
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the chances of mating-pair formation and concurrently lowers the limit of detection for gene 
transfer (Alpert et al. 2003;Doucet-Populaire et al. 1992). This also implies that the di-associated 
germ-free rat model overestimates the transfer frequency compared to a normal GI tract though, it 
predicts the possibility of transfer taking place per se. Di-associated germ-free rats have been 
designated a worst-case in vivo model for gene transfer, however, by using a full-microbiota model 
the potential of antibiotic resistance transfer may be overlooked.  
 
4.4 Human microbiota-associated rats 
Germ-free rats constitute the starting point for development of several different models. The di-
associated rat constitute one of the most simple models, however, gradually more complex models 
can be made by inoculation with several different bacterial species that can be specifically chosen 
and carefully composed or be a more or less unspecified microbiota derived from human fecal 
samples for development of the human microbiota-associated (HMA) model.  
In the HMA model, germ-free animals receive a single inoculation with a complex human 
microbiota and thereafter, gradual selection of the microbiota takes place to suit the environment in 
the new host (Bernbom et al. 2006;Licht et al. 2007). Standardisation of the time after inoculation 
and until initiation of the experiment is therefore desirable to minimize variation between 
experiments (Bernbom et al. 2006). This time period should be a compromise between least 
development in the microbiota composition during the experiment and still a good resemblance 
with the originally inoculated microbiota composition.  
The physiology and feed of the rat may as earlier mentioned favour colonization of certain and 
other species than in the human though, the composition of bacteria as a starting point will be 
similar and only their relative concentration will be changed in the model compared to the human 
inoculation material. An exact comparison of the inoculation material and the bacteria selected for 
in the rat is difficult to obtain, since the human microbiota to a large degree consists of non-
culturable and uncharacterized bacteria. Several studies have been performed, applying various 
methods involving cultivation on selective media, PCR-based amplification and fingerprinting 
assays as well as sequencing and identification of specific species etc. A recent study compared 
profiles of rat faecal samples taken two weeks after dosage of a human faecal inoculum and the 
corresponding inoculum (Licht et al. 2007). Denaturing gradient gel electrophoresis (DGGE) on 
PCR amplified 16S rRNA genes and subsequent excision, cloning and sequencing of obtained 
bands were performed, and the results suggested a composition of dominant species that largely 
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were the same in the two hosts. In contrast, a study of HMA mice analysed with terminal restriction 
fragment length polymorphism (T-RFLP) up till eight weeks after administration of inoculum 
concluded that a significant selection occurred in the mice and that the dominant bacterial groups 
therefore varied from those in the inoculum (Kibe et al. 2005).  
Bernbom and coworkers investigated the effect of time on the composition of faecal microbiota of 
HMA rats after inoculation (Bernbom et al. 2006). They reported a similarity of almost 80% when 
comparing the composition of individual animals one weak and four weeks after inoculation, using 
DGGE and T-RFLP on samples amplified by PCR with universal primers. Analysis of the variation 
between rats inoculated with the same faecal material showed similarities of 50% and 63% for 
DGGE and T-RFLP, respectively, at all time points during the experiment. The latter comparison 
also revealed clustering between animals belonging to the same gender i.e. between male and 
female rats. Faster peristalsis and thus transit times in the larger males was suggested to exert these 
variations in colonization pattern however, other genetic differences could also be influential 
(Bernbom et al. 2006).  
In conclusion, the HMA model is subject to selection at some degree and there may be differences 
between individuals, gender and time after inoculation, but also age of the animals and animal 
species etc. Some of these factors can be accounted for in the experimental set-up, whereas others 
are implicit variations. Despite this, I think that the HMA model has many applications to 
investigate complex bacterial ecology in an environment that resembles the human GI tract. The 
model also has the advantage that several rats can be inoculated with the same starting material. 
Compared to experiments performed with human volunteers where large differences between 
individuals may blur the results, variations between rats may be small and fewer “replicates” 
therefore needed to determine statistic significant results. 
 
4.5 Antibiotic-treated animals 
Antibiotic-treated animals such as rats and mice are other commonly used models of the human GI 
tract. Treatment with antibiotics such as streptomycin disturbs both aerobic and anaerobic 
components of the microbiota, which in turn affects parameters such as pH (increasing) and the 
concentration of volatile fatty acids (decreasing) in intestinal contents (Que et al. 1986). The 
colonization barrier is thus impaired compared to a full microbiota model and chances of the chosen 
test bacteria colonizing the GI tract are concurrently improved.  
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Typical use of the antibiotic-treated animal model includes treatment of the animals immediately 
prior to inoculation with the test bacteria and sometimes also during the experiment. A requirement 
of the test bacteria is therefore that they are either intrinsic resistant or made resistant to the 
respective antibiotics. Compared to the HMA model, which also have a high colonisation barrier 
and a more realistic composition of the microbiota to simulate that in the human GI tract, the 
antibiotic-treated animals have a more “mature” microbiota. The microbiota is inherited to fit the 
animal, which may be important for the authenticity of the model in relation to colonisation of the 
intestinal microniches. In antibiotic-treated animals, the intestine has gone through a realistic 
colonisation phase where probably all available niches are occupied by the bacteria best adapted for 
these. In contrast, the bacteria occupying the corresponding niches in the HMA model have not 
endured the same selection and may not comprise an equivalently strong colonisation barrier.  
 
 43
5. Results 
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Abstract 
This paper reports the complete 4031 bp nucleotide sequence of the small erythromycin resistance 
plasmid pLFE1 derived from the raw-milk cheese isolate Lactobacillus plantarum M345. Analysis 
of the sequence revealed the coding regions for the erythromycin resistance determinant erm(B) and 
a small erythromycin leader peptide suggested to be involved in regulation of erm(B). A replication 
initiation protein repB was identified belonging to the RepB proteins of the pMV158 family of 
rolling-circle replicating (RCR) plasmids. Two elements, the transcriptional repressor protein copG 
and a small countertranscribed RNA (ctRNA), typically involved in replication control within this 
family were also found. A putative replication initiation site including a single-strand origin (sso) -
like region succeeded by a characteristic pMV158 family double-strand origin (dso) was located 
upstream of the replication region. Moreover, we suggest the presence of a secondary replication 
initiation site including an sso and a pC194-type dso. An open reading frame (ORF) preceded by a 
typical origin of transfer (oriT) site and coding for a putative truncated mobilization (Mob) protein 
with a size of 83 aa was detected. The putative mob gene showed large similarity to the N-terminal 
region of the pMV158 family of Pre/Mob proteins, but was much smaller than other proteins of this 
family. We therefore suggest that the Mob function in pLFE1 is supplied in trans from another 
plasmid present in L. plantarum M345.     
Filtermating experiments were performed in order to determine the ability of pLFE1 to be 
transferred to and replicate in different species of Gram-positive bacteria. pLFE1 was shown to 
have a broad host-range with transconjugants obtained from Lactobacillus rhamnosus, Lactococcus 
lactis, Listeria innocua, the opportunistic pathogen Enterococcus faecalis and the pathogen Listeria 
monocytogenes.  
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Introduction 
Lactobacillus plantarum is a species of substantial industrial importance and has been used for 
centuries as starter culture in the manufacture of a broad selection of food products both for human 
and animal consumption. In addition, many strains of L. plantarum are recognized to have a general 
beneficial health effect, and are thus used as probiotics. L. plantarum is often well adapted to 
survive passage through the upper gastrointestinal tract and has frequently been shown to be one of 
the dominating Lactobacillus species in the human small intestine (Ahrne et al. 1998;Johansson et 
al. 1993).  
Natural resident plasmids are common in L. plantarum and several papers have reported the 
nucleotide sequence of these: pWCFS101, pWCFS102, pWCFS103 (van Kranenburg et al. 2005), 
p256 (Sorvig et al. 2005), pPB1 (las Rivas et al. 2004), pPLA4 (van Reenen et al. 1998), pA1 
(Vujcic and Topisirovic 1993), pLB4 (Bates and Gilbert 1989) and pC30il (Skaugen 1989). 
However, most plasmids in lactobacilli are small rolling-circle replicating (RCR) cryptic plasmids 
without any assigned function besides their own replication apparatus and occasionally mobilization 
genes (Pouwels and Leer 1993). Some documents exist on the occurrence of antibiotic resistance 
genes harboured on Lactobacillus plasmids, however, the number is relatively limited (Axelsson et 
al. 1988;Fons et al. 1997;Gevers et al. 2003a;Lin et al. 1996;Tannock et al. 1994;Vescovo et al. 
1982). Due to the wide environmental distribution of L. plantarum, the presence of antibiotic 
resistance plasmids in this species can be a potential health hazard. If mobile, the plasmids may be 
transferred to other bacteria within the food chain and in worst-case reach potentially pathogenic 
bacteria invading the consumer. Transfer of different L. plantarum plasmids harbouring resistance 
genes towards erythromycin and tetracycline has been documented in vitro to Enterococcus faecalis 
and Lactococcus lactis (Gevers et al. 2003b) and in vivo to E. faecalis using gnotobiotic rats as a 
model of the human intestine (Jacobsen et al. 2007). 
The present paper reports on the small L. plantarum erythromycin resistance plasmid pLFE1, 
previously shown to transfer at high frequency to E. faecalis in the gnotobiotic rat model but not in 
the more complex streptomycin-treated mice model (Feld et al. 2008). The whole nucleotide 
sequence of pLFE1 was determined and analysis was carried out in order to learn more about the 
mechanistic basis for mobilization, potential host-range, incompatibility grouping and expression of 
antibiotic resistance.  
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Materials and methods 
Bacterial strains, plasmids and culture conditions 
The raw-milk cheese isolate Lactobacillus plantarum M345 (Feld et al. 2008) previously shown to 
harbour the erythromycin resistance plasmid pLFE1 was used for plasmid preparation of pLFE1 
and as donor in in vitro conjugation assays. Strain M345 was grown anaerobic at 37 °C for 24-48 h 
in de Man, Rogosa and Sharpe (MRS) medium (Oxoid, Hampshire, UK) supplemented with 
erythromycin when appropriate (for concentrations, see below). 
Bacterial strains used as recipients in the conjugation study are listed in Table 1. When appropriate, 
antibiotics were added to the media at the following final concentrations: 100 µg ml-1 or 500 µg ml-1 
streptomycin (str) for selection of Bacillis sp. and Enterococcus faecalis, respectively, 500 µg ml-1 
spectinomycin (spec), 25 µg ml-1 tetracycline (tet), 100 µg ml-1 rifampicin (rif) and 100 µg ml-1 
nalidixic acid (nal). Erythromycin was applied at 16 or 50 µg ml-1 for selection of transconjugants 
and donors, respectively.  
 
Sequencing of pLFE1 plasmid  
The erm(B) gene harboured on plasmid pLFE1 from L. plantarum M345 was analysed by 
sequencing standard PCR products. Plasmids were extracted from the strain as earlier described 
(Jacobsen et al. 2007) and subsequently used as template in PCR amplification of the erm(B) gene, 
as previously described (Jacobsen et al. 2007). Eight PCR reactions were set up, and the eight 
products pooled and purified using the MinElute PCR Purification Kit (Qiagen, Hilden, Germany). 
The size of the PCR product (424 bp) was confirmed by gel electrophoresis and the sample 
subsequently sequenced using the ermB-F and ermB-R primers (Jensen et al. 1999). The remaining 
part of the L. plantarum M345 erm(B) plasmid was sequenced by primer walking using the plasmid 
preparation of strain M345 as template. Initially, the primers Lor1 (5’-AGA TGA CTG TCT AAT 
TCA ATA G-3’) and Lor3 (5’-TGC ACA CTC AAG TCT CGA-3’) targeting the erm(B) gene and 
reading outwards, were applied. All sequencing reactions were performed at GATC Biotech 
(Konstanz, Germany). 
 
Verification of pLFE1 structure 
A restriction map of pLFE1 was made by digestion with the restriction enzymes XcmI, XmnI, AseI, 
HincII, BssSI and NdeI. As template, plasmid extraction from a pLFE1-carrying transconjugant 
isolate previously obtained by conjugation between L. plantarum M345 and E. faecalis JH2SS was 
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used (Feld et al. 2008). Analysis of the plasmid profile showed that this isolate contained the pLFE1 
plasmid solely. Restriction analysis was performed using restriction enzymes from New England 
Biolab (Herts, UK) according to the description of the manufacturer. Digested DNA was run by gel 
electrophoresis on a 1% agarose gel and subsequently stained with ethidium bromide.  
The structure of pLFE1 was further confirmed by PCR using primers mob1F (5’- TGG GTC AAT 
CGA GAA TAT C-3’) binding at position 1213-1231, mob2F (5’-GAT TTG GTC AAT CGG ACA 
G-3’) binding at position 3444-3462 and mobR (5’-GAA CGC AAA TAT GAG CTT C-3’) binding 
at position 3729-3711 and 1623-1605. As template, plasmid preparations of L. plantarum M345 or 
transconjugants previously obtained from mating between L. plantarum M345 and E. faecalis 
JH2SS were used (Feld et al. 2008). PCR mixtures were prepared using 5 µl DNA template, 1 
PuReTaq Ready-To-Go PCR bead (Amersham Biosciences, Buckinghamshire, UK) and 20 pmol of 
each primer in a total volume of 25 µl. Amplification using the primers mob1F + mobR or mob2F + 
mobR should result in a 286 bp and a 411 bp PCR product, respectively. PCR was carried out by 
initial denaturation at 95 ºC for 10 min followed by 30 cycles of 95 ºC for 45 s, 55 ºC for 45 s and 
72 ºC for 2 min. A final extension step at 72 ºC for 10 min ended the programme.  
 
In vitro mating experiment 
The ability of plasmid pLFE1 to be transferred to and replicate in different Gram-positive species 
was assessed using a filter-mating assay. The donor and recipient strains were grown in broth 
supplemented with the respective antibiotics to an OD600 = 0.7-1.0. The bacteria were mixed in 
equal volumes and vacuum filtered onto sterile filters (HAWP04700). The filters were placed on 
agar mating plates and incubated overnight at conditions optimal for the recipients (for media and 
incubation conditions, see Table 1 – however for mating with Listeria sp. and Bacillus sp., BHI 
were used as mating medium instead of selective agars). The bacteria were subsequently washed off 
the filters and suitable dilutions prepared on plates selective for donor, recipients (Table 1) and 
transconjugants. Transconjugants were selected at conditions identical to their respective recipients 
except that erythromycin was added to the plates and the plates were incubated for 36h. Controls of 
separate donor and recipient plates were also prepared. The experiment was performed in 
triplicates.  
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Verification of transconjugants 
In order to verify that colonies isolated from selective agar plates were true transconjugants and not 
mutants of either donor or recipient, specific PCR and fingerprinting assays were performed. The 
presence of the erm(B) gene was verified by PCR using primers specific for erm(B) as earlier 
described (Jacobsen et al. 2007). Donor and recipients were included as positive and negative 
controls, respectively. Random amplified polymorphic DNA (RAPD) technique was used to show 
similar fingerprints of recipients and transconjugants and differentiate them from the fingerprint of 
the donor. Template DNA of donor, recipients and transconjugants was prepared as previously 
described (Jacobsen et al. 2007). The PCR reaction mixtures contained 5 µl DNA template, 1 
PuReTaq Ready-To-Go PCR bead (Amersham Biosciences) and 20 pmol of primer OPA-02 
(Operon Biotechnologies, Cologne, Germany) in a total volume of 25 µl. The PCR programme was 
as follows; initial denaturation 94 ºC for 4 min followed by 40 cycles of 94 ºC for 1 min, 32 ºC for 1 
min and 72 ºC for 2 min. The program was ended by extension at 72 ºC for 5 min. Isolates of 
Listeria monocytogenes transconjugants were further tested by PCR using primers IntA_C_up (5’-
TAG AAG TAG TGT AAA GAG CTA GAT G-3’) and IntA_C_down (5’-ATA TAA AGC TTG 
CGG CCG CTT CTG CAA AAG CAT CAT CTG GAA AA-3’) amplifying a 260 bp sequence of 
the virulence gene IntA coding for Internalin A. PCR reaction mixtures contained 5 µl DNA 
template, 1 PuReTaq Ready-To-Go PCR bead and 20 pmol of each primer IntA_C_up and 
IntA_C_down in a total volume of 25 µl. The PCR programme was as follows; initial denaturation 
at 95 ºC for 3 min followed by 30 cycles of 95 ºC for 30 s, 55 ºC for 30 s and 72 ºC for 30 s and 
finally extension at 72 ºC for 3 min. The donor and recipient were included as negative and positive 
controls, respectively.  
All PCR amplifications were performed in a PTC-225 Peltier Thermal Cycler (MJ Research, Bio-
Rad, Waltham, MA, USA). The PCR products were run on a 1.5% agarose gel for 1h and visualized 
by ethidium bromide staining. 
  
Nucleotide sequence analysis 
Analysis of the complete nucleotide sequence for open reading frames (ORF) was performed using 
the web-based NCBI ORF Finder programme. Database searches and comparisons of DNA 
sequences or DNA-derived protein sequences were carried out using BLASTN, BLASTP and 
BLASTX programmes (Altschul et al. 1990). Multiple sequence alignments were made with the 
ClustalW2 program (Larkin et al. 2007) and alignments of conserved domains of proteins encoded 
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on pLFE1 was retrieved from the Conserved Domain Database (CDD) (Marchler-Bauer et al. 
2007). Secondary structure and calculation of free energy for hairpin formations was determined 
using the Mfold programme (Zuker 2003). 
 
Nucleotide sequence accession number 
The complete nucleotide sequence of pLFE1 (see appendix) will be deposited into GenBank.  
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Results and Discussion 
General features of pLFE1 sequence  
The complete nucleotide sequence of plasmid pLFE1 was determined to be 4031 bp in length. The 
correctness of the deduced pLFE1 nucleotide sequence was verified with single digests using the 
restriction enzymes shown in Fig. 1 and gel electrophoresis, which confirmed the predicted 
nucleotide band sizes. The average G + C content of pLFE1 is 34.4%, which is lower than that of 
the L. plantarum chromosome average of 44.5% (Kleerebezem et al. 2003), but within the range 
described for other small L. plantarum plasmids such as pA1 (34.9%) (Vujcic and Topisirovic 
1993), pPB1 (37.4%) (las Rivas et al. 2004), p256 (37%), pWCFS101 (39.5%) and pWCFS102 
(34.3%) (van Kranenburg et al. 2005). Analysis of the whole nucleotide sequence revealed 16 
putative ORFs of at least 33 aa in length and one ORF smaller than 33 aa (Table 2). In a region of 
3-12 nucleotides upstream of each of the ORFs, analysis was carried out for detection of ribosome-
binding sites (RBS) using the L. plantarum RBS sequence GGAGG as consensus (Pouwels and 
Leer 1993). However, in many cases either no or only poor potential RBS sites could be detected 
and translational coupling to other putative proteins did not seem plausible. In addition, several of 
the ORFs showed either very low or no significant similarity to other proteins deposited in the 
databanks, and altogether these ORFs were considered artefacts.  
 
Replication initiator (RepB) protein 
A putative replication initiator (RepB) protein was identified at position 2421-3059 (212 aa) (Fig 1 
+ Fig. 2), showing high similarity to the RepB proteins of the L. plantarum rolling-circle replicating 
(RCR) plasmid pLB4 (80% identity over 211 aa) (Bates and Gilbert 1989), RCR plasmid pLF1311 
from Lactobacillus fermentum (82% identity over 206 aa) (Aleshin et al. 1999) and RCR plasmid 
pBM02 (71% identity over 205 aa) from L. lactis subsp. cremoris (Sanchez and Mayo 2003). The 
putative RepB protein showed a conserved domain architecture corresponding to that of Rep_2 
plasmid replication proteins (pfam01719) in the Conserved Domain Database (CDD). The sequence 
included three motifs (Fig. 2 + Fig. 3) typical for plasmid family pMV158 (Ilyina and Koonin 
1992). These motifs include the putative binding site for Mg++ (motif II), which is thought to be 
required for nicking activity and the active tyrosine residue (motif III) involved in the catalytic 
attack of the plasmid DNA during initiation of replication (del Solar et al. 1998;Dyda and Hickman 
2003;Ilyina and Koonin 1992).  
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Plasmid copy number control 
A putative copG gene (59aa) previously referred to as repA was found at position 1914-1735 bp 
(Fig. 1 + Fig. 2), showing high similarity to repA (70% identity over 51 aa) of pLB4 (Bates and 
Gilbert 1989), repA (70% identity over 51 aa) of pLF1311 (Aleshin et al. 1999), repA (68% identity 
over 51 aa) of the L. lactis plasmid pAR141 (Raha et al. 2006) and repA (69% identity over 46 aa) 
of pBM02 (Sanchez and Mayo 2003). The putative CopG protein revealed a conserved sequence 
structure similar to the RHH_1 ribbon-helix-helix family of CopG repressor proteins (pfam01402 in 
the Conserved Domain Database) (Fig. 4).  
CopG is a transcriptional repressor protein that regulates the plasmid copy number in the pMV158 
derivative plasmid pLS1 (del Solar et al. 1995;del Solar and Espinosa 1992). By binding to the 
single copG-repB promoter region, CopG prevents host RNA polymerase binding and thus repress 
the synthesis of the replication initiation protein RepB as well as itself (del Solar et al. 1990). A 
structure of the replication region comparable to pLS1 has also been revealed in other plasmids 
belonging to the pMV158 family suggesting that they are controlled in a similar fashion (Bates and 
Gilbert 1989;Cocconcelli et al. 1996;Raha et al. 2006;Vujcic and Topisirovic 1993). Sequence 
analysis of pLFE1 indicated a homologous architecture with a putative promoter 18 nucleotides 
upstream of the copG start codon with a –35 (TTGTAT) and –10 (TATAAT) sequence in a distance 
of 17 base pairs and typical RBS sites located upstream each gene, copG and repB (Fig. 2). 
However, no sequence matching the criteria of a 13-bp pseudosymmetric element overlapping the -
35 copG-repB promoter box could be found. This element was demonstrated to be the target 
binding site of CopG in pLS1 (del Solar et al. 1990) and homologous sequences have been detected 
in other pMV158 family plasmids, although their function have not been elucidated (del Solar et al. 
2002). 
The active DNA binding unit of CopG from plasmid pMV158 has been shown to display a 
characteristic ribbon-helix-helix (RHH) motif, which is built up around a glycine residue mediating 
a turn between two α-helices. At conserved positions of the α-helices specific residues are required 
to maintain the hydrophobic core of the motif (Gomis-Ruth et al. 1998). Within the putative copG 
gene of pLFE1 the presence of a glycine residue and specifically positioned hydrophobic residues 
were established (Fig. 4). 
Apart from CopG, a small countertranscribed RNA (ctRNA) of approximately 50 nucleotides in 
size has been shown to control the plasmid copy number of pLS1 (del Solar et al. 1995;del Solar et 
al. 1997). The ctRNA is transcribed in the opposite direction of the mRNA encoding the RepB 
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protein and thus inhibits translation of RepB by binding to a region of the copG-repB mRNA, 
which includes the RBS of repB (del Solar et al. 1997). Similar genetic organizations of ctRNA are 
present in other members of the pMV158 family. Thus, the coordinate action of the two plasmid-
encoded elements CopG and ctRNA has therefore been suggested to be a common mode of plasmid 
copy number regulation in the pMV158 plasmid family (del Solar and Espinosa 1992). Indeed, 
sequence analysis of pLFE1 revealed a putative ctRNA encoded on the complementary strand in the 
region between copG and repB (Fig. 1 + Fig. 2). Within the amino-terminal region of repB a 
putative promoter consisting of less conserved –10 (TTTCAT) and –35 (TAGGCA) boxes in a 
distance of 18 nucleotides was detected. A possible transcriptional terminator was found 
overlapping the carboxyl-terminal end of copG. This plausible terminator could be a rho-
independent site, containing an inverted repeat configuring a potential hairpin structure followed by 
a T-stretch (depicted by an A-stretch at the complementary strand in Fig. 2).  
 
Origin of replication 
In RCR plasmids the double-strand origin (dso) is the initiation site of leading-strand synthesis. The 
dso contains a nic site, which generally is well conserved within each plasmid family and a binding 
site showing larger sequence variation (Khan 1997). Within pLFE1 a region of 22 bp (5’-
atGGGGGcACTACGACaCCCCC-3’) showing high similarity (four mismatches) to the pMV158 
family nic sites (del Solar et al. 1998) was found 162 bp upstream of copG at position 1934-1955 bp 
(Fig. 1 + Fig. 2). This region showed 100% similarity to the dso of both L. fermentum (Aleshin et 
al. 1999) and the shuttle vector pLF14 (unpublished, Accession No. X85436.1). The putative nic 
site of pLFE1 was contained within an inverted repeat (IR5 with a calculated free energy dG = -8.4 
kcal/mol) and flanked by a direct repeat (DR) (Fig. 2), which is suggested to be the binding site of 
RepB. In other RCR plasmids, binding and interaction with RepB has been shown to change the 
secondary structure resulting in creation of a hairpin, which in turn exposes the nic site and thus 
initiates replication (Khan 1997).  
A region of 266 nucleotides immediately upstream of the putative dso showed a large potential of 
palindromic structures (dG = -50.6 kcal/mol) (Fig. 1 + Fig. 2). We propose that this region 
constitutes the single-strand origin (sso) of pLFE1 from where lagging-strand synthesis is initiated. 
Ssos are characterised by substantial secondary structure, but the sequence homology may be very 
low even between plasmids belonging to the same family (Gruss and Ehrlich 1989;Khan 1997). 
Comparison of the putative sso sequence of pLFE1 with four types of ssos (ssoA, ssoU, ssoT and 
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ssoW) previously described (Kramer et al. 1999) showed no general sequence similarity (data not 
shown). However, an RSB (recombination site) or RSB-like site (5’-TTTTCGTCGGCATAA-3’) 
was recognized at position 1669-1683 (Fig. 2) at the basis of the stem of a putative hairpin structure 
(dG for IR1 = -33 kcal/mol). This site has apart from being a recombination site been proposed to 
be involved with host RNA polymerase binding to the sso. The RSB may therefore be critical for the 
synthesis of a primer RNA that can be used to initiate lagging-strand replication. The RSB was first 
recognized in ssoA origins, but homologues have been detected in the other types of ssos as well 
(Kramer et al. 1999). 
A second region of plasmid pLFE1 potentially containing an origin of replication was found in the 
non-coding area downstream the putative mob gene. A sequence of 20 bp (5’-
TtcTTCTTATCTTGATAcTA-3’), which showed high homology (three mismatches) with pC194 
family dsos was found at position 4009-4028 (Fig. 1) (del Solar et al. 1998;Wu et al. 2007). This 
sequence showed 100% identity with the putative dso of the L. plantarum plasmids pLP1 (Bouia et 
al. 1989) and pC30il (Skaugen 1989) and the L. lactis plasmid pWC1 (Pillidge et al. 1996).  
Upstream of the putative dso another potential sso region of 240 nucleotides (Fig. 1), which showed 
high potential of palindromic structures (dG = -63.2 kcal/mol) was detected. This region contained 
an RSB-like sequence 100% identical to the one described above, which also was placed at the basis 
of the stem of a potential hairpin structure (dG = -35.2 kcal/mol). The sequences pursuing these two 
identical RSB-like sequences were 75% identical with the similarity discontinuing upstream of the 
putative dsos (data not shown). Thus, despite the lack of overall sequence homology to any 
previously known ssos, we suggest the presence of two ssos within pLFE1. The existence of two 
functionally intact ssos simultaneously present on a single plasmid has earlier been reported for 
pMV158, which has been shown to contain both an ssoA and ssoU type (van der Lelie et al. 1989).  
 
Erythromycin resistance  
A putative antibiotic resistance gene erm(B) conferring resistance to macrolide, lincosamides and 
streptogramin (MLS) antibiotics were located at position 625-1362. The erm(B) gene encodes a 
protein 100% identical to the erythromycin ribosome methylase Erm(B) of E. faecium (De Leener 
et al. 2005). The group of Erm(B) proteins is relatively well-conserved showing 98-100% similarity 
at the nucleotide level (Roberts et al. 1999). Erm(B) enzymes confer resistance by adding one or 
more methyl groups to a specific adenine residue located in the 23S rRNA subunit thereby 
preventing binding of the antibiotic (Weisblum 1995a).  
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A small region (27 aa) was identified 124 nucleotides upstream the erm(B) start codon, which at its 
full length showed 100% identity with MLS leader peptides from a range of mobile elements 
harboured in different bacterial species. The functional role of MLS leader peptides is to regulate 
expression of the erythromycin methylase by conformational changes of the secondary structure of 
the mRNA, which affects the neighbouring region upstream of the methylase (Weisblum 1995b). In 
the absence of erythromycin, translation of the leader peptide is active. Hereby, it assumes a 
configuration that positions the RBS site and initial codons of the methylase within the stem of a 
hairpin structure, thus preventing its translation. However, when erythromycin is present, it binds to 
and suspends ribosomes involved in translation of the leader peptide. This in turn induces a 
conformational change and thereby exposes the RBS site of the methylase thereby promoting its 
translation (Weisblum 1995b).  
Several isolates have been reported constitutively to produce erythromycin methylase although 
putative MLS leader peptides were detected (Gfeller et al. 2003;O'connor et al. 2007). However, the 
putative MLS leader peptide of pLFE1 is identical to leader peptides from strains of Streptococcus 
pneumoniae, which have been reported functional (Okitsu et al. 2005). Compared to the leader 
peptide in the erm(B) gene of Tn917 (Shaw and Clewell 1985) the peptide in pLFE1 is only 27 aa 
i.e. 9 aa shorter due to a single mutation resulting in an earlier stop codon. A previous study 
suggested that a similar mutation caused an increased level of methylase translation, resulting in an 
apparently constitutive resistant phenotype. The mutation increased the basal methylase activity by 
approximately 3.8 fold and the induced activity by approximately 4.9 fold (Oh et al. 1998).       
    
Mobilization region 
A truncated recombinase/mobilization (pre/mob1) gene (Fig. 1) was found at position 1386-1606 
(73 aa), which showed 100% nucleotide identity with the carboxyl-terminal end of the 
Lactobacillus sakei plasmid pYS18 Pre/Mob protein (unpublished, Accession No. EU185047) and 
94% nucleotide identity with the Pre/Mob protein of L. lactis subsp. lactis plasmid pK214 
(unpublished, Accession No. YP_001429536). However, despite the presence of an ATG start 
codon, no potential RBS or transcriptional coupling could be detected (Table 2) thus rendering 
transcription of this protein unlikely. 
In a different region of pLFE1 a second truncated pre/mob2 gene was found at position 3312-3563 
bp (83 aa). A strong RBS site (AGGAG) was located seven nucleotides upstream of the ATG start 
codon and a possible promoter was found with a -35 box (TTACGA) and a -10 box (TATACT) in a 
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distance of 17 nucleotides (Fig. 5). The pre/mob2 gene showed 94% nucleotide identity with the 
amino-terminal end of the Pre/Mob protein of pK214 and 81% nucleotide identity with the Pre/Mob 
protein of pYS18. Sixtyone nucleotides downstream of the pre/mob2 stop codon a fragment 
showing 93% nucleotide identity with the carboxyl-terminal end of the pK214 Pre/Mob protein and 
96% nucleotide identity with the Pre/Mob protein of pYS18 was found (Fig. 5). However, no start 
codon or putative RBS could be identified for this small fragment.  
The odd sequence structure of pLFE1 with several truncated pre/mob genes or gene fragments was 
verified by PCR using primers mob1F, mob2F and mobR (data not shown). The mob2F + mobR 
primers were specifically designed to confirm the short distance of 61 nucleotides and thus lack of a 
middle region of the pre/mob gene between the amino-terminal pre/mob2 gene and the carboxyl-
terminal pre/mob
 
fragment. Mob1F + mobR were designed to confirm the spatial separation of 
pre/mob1 and pre/mob2 with the former placed downstream of erm(B).  
The Pre/Mob proteins of pK214 and pYS18 belongs to the pMV158 family of Pre/Mob proteins 
that functions both in mobilization and recombination (Pre for plasmid recombination enzyme) 
(Francia et al. 2004). The Pre/Mob family contains within the amino-terminal region three highly 
conserved motifs considered to form part of the catalytic centre of the relaxase enzyme. In the 
pre/mob2 region of pLFE1 only two of the three motifs could be identified (Fig. 5). Additionally, 
the size of the putative Pre/mob2 is only 83 aa in contrast to other considerably larger Pre/Mob 
proteins (approximately 350-500 aa) belonging to this family (Gennaro et al. 1987;Josson et al. 
1990;las Rivas et al. 2004;Somkuti and Steinberg 2007).  
Mobilization proteins normally demonstrate relaxase activity and are thus essential in preparation of 
the plasmid for transfer (Francia et al. 2004). In plasmid pMV158 the Pre/Mob protein has been 
shown to nick supercoiled plasmid DNA at the origin of transfer (oriT) (Guzman and Espinosa 
1997) and without the presence of an intact Pre/Mob protein conjugal transfer was suspended 
(Priebe and Lacks 1989;van der Lelie et al. 1990). Since pLFE1 has been shown transferable but 
does not seem to contain an intact Pre/Mob protein, we suggest that it must be supplied in trans in 
L. plantarum M345. This organization has been shown functional in Bacillus, where transfer-
deficient Mob- hybrid plasmid constructs of pUB110 and pBC16 could be mobilized by 
complementation of a Mob protein in trans (Selinger et al. 1990).  
Apart from relaxase activity, which could be provided in trans, the presence of an oriT region in cis 
has been shown to be a minimal requirement for mobilization of plasmids such as pUB110 and 
pBC16 (Selinger et al. 1990). The oriT site is very similar among members of the pMV158 family 
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and is located upstream of the mob gene, overlapping its promoter. OriT has a conserved hairpin 
structure with an IR of 7-10 nucleotides forming the stem and a loop of usually 6 nucleotides 
presenting the nic site (Francia et al. 2004;Guzman and Espinosa 1997). A putative oriT site 
matching these criteria was identified in pLFE1 at position 3257-3276, 34 nucleotides upstream of 
the pre/mob2 start codon. A putative –10 promoter box was embedded within this sequence and an 
IR consisting of 8 nucleotides interrupted by 6 nucleotides was also recognized (Fig. 5).  
 
Plasmid recombination 
Apart from being the origin of transfer, oriT also functions as a putative recombination site (RSA). 
The plasmid-encoded Pre/Mob protein mediates site-specific recombination at RSA in trans 
(Gennaro et al. 1987). Analysis of several plasmids has shown a marked sequence divergence at the 
RSA site with the one side showing significant homology to one plasmid and the other side showing 
homology to a second plasmid – thus indicating development by recombination of the plasmids at 
their respective RSA sites (Hauschild et al. 2005;van der Lelie et al. 1989). In pLFE1 a similar 
organization was detected where the sequence including and upstream RSA exhibits 96% nucleotide 
identity with a region of the L. lactis plasmid pK214, yet the sequence immediately downstream 
RSA presents no significant similarity to pK214 but 96% identity with regions of the L. plantarum 
plasmids pPLA4 (van Reenen et al. 1998) and pPB1 (las Rivas et al. 2004) (data not shown). 
However, pLFE1 has a very unusual sequence structure amongst others with several interrupted 
pre/mob regions suggesting that pLFE is the product of several relatively recent recombination 
events. The presence of pre/mob1 could be the result of recombination with pYS18, since a fragment 
of 308 nucleotides including pre/mob1 shows 100% nucleotide identity with pYS18. The similarity 
starts with G in the putative ATG start codon and the complete identity continues ten nucleotides 
downstream of the RSB recombination site (data not shown).  
       
In vitro mating experiment 
A filter-mating assay was used to assess the ability of pLFE1 to be conjugated to and replicate in 
different Gram-positive bacteria. Potential pLFE1-carrying transconjugants was isolated on 
selective agar plates from matings with E. faecalis, L. rhamnosus, L. lactis, L. monocytogenes and 
L. innocua recipients. These isolates were confirmed to be true transconjugants by PCR using 
specific primers and by RAPD fingerprinting (data not shown). No transfer was detected to the 
recipients B. subtilis and B. thuringiensis under the experimental conditions applied (data not 
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shown). However, transfer and maintenance of pLFE1 in the Bacillus species cannot be excluded 
from the present results, but may be possible under different conditions.    
 
Host-range of pLFE1 
The in vitro mating experiment included in this study established the ability of a broad range of 
Gram-positive species to function as hosts of pLFE1. An important factor for the stable 
maintenance of RCR plasmids in a host is the presence of a compatible sso, since lack of this will 
result in accumulation of single-stranded plasmid DNA (Leer et al. 1992;van der Lelie et al. 1989) 
and subsequently segregation (Gruss and Ehrlich 1989). The efficiency of the host RNA polymerase 
to bind to the plasmid sso promoter sequence has earlier been suggested as a key factor deciding the 
compatibility between the host and the plasmid (Kramer et al. 1998;Kramer et al. 1999). In pLFE1, 
the observed broad host-range could imply the presence of an ssoU type of sso, since the other types 
of ssos seem to function optimally only in their natural hosts, possibly due to a more specific 
binding site. In contrast, ssoU has been isolated from a broad range of Gram-positive bacteria such 
as B. subtilis, Staphylococcus aureus, S. pneumoniae and L. lactis (Kramer et al. 1999).  
Analysis of the pLFE1 nucleotide sequence failed to detect the presence of a typical mob gene, but 
rather revealed a number of truncated genes or fragments with similarity to the pMV158 family of 
recombination and mobilization proteins. Members of this family have been shown to replicate both 
in Gram-positive and Gram-negative hosts, and mobilization of these can be facilitated by a wide 
range of helper plasmids such as the Gram-positive conjugative plasmids pIP501, pAMβ1, pLS20, 
pXO11, pXO12 and pAD1 as well as Gram-negative broad host-range plasmids belonging to 
incompatibility group IncW, IncF and IncP and conjugative transposons like Tn916, Tn925 and 
Tn1545 (for a review, see (Francia et al. 2004). However, whether the mob genes found in pLFE1 
are functional and can provide the relaxase activity needed to initiate plasmid transfer is uncertain 
and requires further study. However, we suggest that the mob function of pLFE1 is supplied in 
trans from another plasmid present in the L. plantarum M345 host. If a functional mob gene is 
absent in pLFE1, it significantly reduces the probability of dissemination of pLFE1 from hosts other 
than L. plantarum M345. Hence, in order to sustain transfer, both a mob gene compatible with the 
pMV158 type of oriT and a tra gene facilitating the mating channel between the new host and 
recipient will be required in trans.  
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Conclusion 
In this paper we have analysed the nucleotide sequence of plasmid pLFE1 and found two regions 
containing a putative double-strand origin and single-strand origin suggesting that pLFE1 replicates 
via a rolling-circle mechanism. Furthermore, analysis of the replication region places pLFE1 in the 
pMV158 family of RCR plasmids. We have shown that PLFE1 has a broad-host range, however the 
presence of a typical mob gene could not be confirmed. Instead, several truncated genes with 
similarity to the pMV158 family of Pre/Mob proteins were detected. Analysis of the Mob function 
in pLFE1 requires further study.  
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Recipient strains Resistances Recipient selection Source or reference 
Enterococcus faecalis 
OG1SS 
Strr, specr BHI + str + spec, 37 C, 
aerob, 24-48h 
(Franke and Clewell 
1981) 
Lactobacillus 
rhamnosus  
VTT E-042730 
Tetr MRS + tet, 30 C, anaerob, 
36h 
VTT  
 
Lactococcus lactis 
BU2-60 
Strr, Rifr GM17 + rif + str, 30 C, 
aerob, 24-48h 
(Neve et al. 1984) 
Listeria 
monocytogenes LO28 
Nalr Palcam + nal, 37 C, aerob, 
24-48h 
(Vicente et al. 1985) 
Listeria innocua DSM 
20649 
Nalr palcam + nal, 37 C, aerob, 
24-48h 
DSMZ 
Bacillus subtilis AW59 Strr BSA agar + str, 30 C, 
aerob, 24-48h 
(Wilcks, A., unpublished 
data) 
Bacillus thuringiensis 
GBJ01 
Strr BSA agar + str, 30 C, 
aerob, 24-48h 
(Jensen et al. 1995) 
Table 1:
 BHI - Brain Heart Infusion Medium; GM17 - M17 Medium supplemented with 0.5% glucose; Palcam Agar 
Base supplemented with Palcam Selective Supplement; BSA - Bacillus cereus Selective Agar Base supplemented with 
Bacillus cereus Selective Supplement and Egg Yolk Emulsion. All media were purchased from Oxoid and prepared 
according to manufacturers instructions. DSMZ: German Collection of Microorganisms and Cell Cultures. VTT Culture 
Collection, Finland. 
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Name strand Size 
(aa) 
Position 
(bp) 
Mol% 
G + C 
RBS % aa identity  Best BLAST match Accession 
no. 
Erm(B) 
leader 
peptide 
+ 27 417-500 29.8 GGAGG 100 (27 aa) 
MLS leader peptide, 
Streptococcus pneumoniae, 
transposon Tn6003 
AM410044 
Erm(B) + 245 625-1362 33.1 GGAGA 100 (245 aa) 
ErmB, Erythromycin 
ribosome methylase of E. 
faecium clone 1 
AAX12187 
ORF 3 + 34 1166-1270  –
 
 no significant similarity  
ORF 4 + 64 1307-1501 31.8 GTACC 73 (34 aa) hypothetical protein, Streptococcus cristatus AAY63933 
pre/mob1 + 73 1384-1605 33.8 _ 100 (72 aa) 
Mob, mobilization protein of 
Lactobacillus sakei plasmid 
pYS18 
ABW71679 
CopG + 59 2118-2297 29.4 AGAGA 70 (51 aa) 
RepA, plasmid copy number 
control protein of L. plantarum 
RCR plasmid pLB4  
P20044 
ORF 7 + 42 2272-2400  CAAGC  no significant similarity  
RepB + 212 2421-3059 33.8 GGAAG 80 (211 aa) 
RepB,
 
replication initiation 
protein of L. plantarum RCR 
plasmid pLB4 
P20045 
 
ORF 9 + 33 3077-3178  –  no significant similarity  
pre/mob2 + 83 3312-3563 32.5 AGGAG 95 (83 aa) 
Mob, mobilization protein of 
L. lactis subsp. lactis plasmid 
pK214 
YP_001429536 
ORF 11 + 33 3442-3543  –  no significant similarity  
ORF 12 + 35 3800-3907  AGCGT  no significant similarity  
ORF 13 
– 
59 338-159  TAAGA 31 (61 aa) C-terminal domain containing protein, Tetrahymena termophila XP_001013113 
ORF 14 – 72 1560-1342  _ 33 (56 aa) hypothetical protein, Paramecium tetraurelia XP_001449055 
ORF 15 
– 
41 1735-1610  GCAAG  no significant similarity  
ORF 16 
– 
36 1763-1653  GCAAA  no significant similarity  
ORF 17 – 65 3176-2979  AGCGC 34 (58 aa) rCG54873, isoform CRA_a, Rattus norvegicus EDL98520 
Table 2:
 Description of putative ORFs in pLFE1. ORFs marked in bold have a high probability of translation as 
predicted from RBS sites and potential translational coupling. 
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Fig. 1:
 Map of plasmid pLFE1 showing elements described in the text and restriction sites for enzymes used for 
nucleotide sequence verification.  
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   1561   AGAAATGAAACTCGAACACGAGATAGAGATGAATTAAGTCGTTAGAAGCTCATATTTGCG 
                   
                                                               RSB        
   1621   TTTTAAGGCGTTTTAAATCAATTCGAGTATATTTATACCTGTTTGGTCTTTTCGTCGGCA 
    
                            IR1 
   1681   TAAGCGTTAAAAATGGCAATAGAAAAAGCAGCAAGGGCGAACGTAGTGAGTGCATTTACC 
     
                         
IR1
     
   1741   CTTGCTGCTTTTTTTGTTGTCATTTAGCTTTTGCATAGACGACGGAAAGCCAACAGGTGT 
                                 
                                          IR2        IR2           IR3   
   1801   GAATGTTTAGCTACTTTTCAGAGGCATGATCAAACGCATTGCGTTTGTGGGTGTGGGCAA 
          
             IR3                                                 IR4 
   1861   CGCCCGCGGTTTTATTAGTTTTTAGGAATTGGGAAGCAAACTGGGGGGAGATTTTGAAAA 
                                            
             
IR4
         
IR5         nick      IR5
        
DR
   
   1921   AATCGACCAACTCATGGGGGCACTACGACACCCCCCATGTGTCCATTGTCCATTGTCCAA 
               
                     
   1981   ATAGATAAAAAGATTAAATGTCTTGTAAATACCTTTATATGAACGTTTTAAGCACCTATT 
           
                                         -35                     -10   
   2041   TCGAGGTGAAAAAAAGTTTTTTGTAAAATCTTGTATTCCTGTCGTATGTATAATATAATT 
                                
                     
RBS 
  
CopG
  
   2101   ACAGTGTAAAAGAGATTTTGAAGAGAATTGAGGTGTATTTTGTGGTTGAAGTTGAGAAGA 
                            M  K  R  I  E  V  Y  F  V  V  E  V  E  K      
       
   2161   AAAAAGTGACTTTATCTTTACCTGTTGAATCGAATGACAAACTAGAAAAAATGGCACAAA 
          K  K  V  T  L  S  L  P  V  E  S  N  D  K  L  E  K  M  A  Q      
           
   2221   AATATGGAATGACTAAATCAGGTTTGGTTACATTTTTAATTAATCAAGCTGATGATAAGG 
          K  Y  G  M  T  K  S  G  L  V  T  F  L  I  N  Q  A  D  D  K      
                                   IR6            IR6 
   2281   GGACTATTTTTAAATAAAAAAAGCCCTGCTAGGAAGATAGCAAGGGCTCGCAAGATTTGG 
          G  T  I  F  K  *                                                 
            
   2341   TTTTCTTTGATTTCGCAACTCAAGTTTATCAAATTTTCCCTTGTTTTCCTAGTAGAGTAA 
     
              RBS             repB      -10                        -35 
   2401   CTAGGAAGGTGTAGAAAAATATGGAAAATGAAAATAGAACAGATTGGACATTGCCTAGAA 
                               M  E  N  E  N  R  T  D  W  T  L  P  R      
               
   2461   AGAATTTAAATCCAAAAACTAAACAGCCTTATAAGCGAGGTCGTAACTGGTGGATTGTTG 
          K  N  L  N  P  K  T  K  Q  P  Y  K  R  G  R  N  W  W  I  V      
              
   2521   TTTATCCTGAAAGTTTGCCAGAGAATTGGAAAGAGATTATTTCAACTGAACCTGTGGCAA 
          V  Y  P  E  S  L  P  E  N  W  K  E  I  I  S  T  E  P  V  A      
           
   2581   TTAGTCCATTACATGATAAAGATGTTAATGCAGACGGAACAAAGAAAAAGCCGCATTATC 
          I  S  P  L  H  D  K  D  V  N  A  D  G  T  K  K  K  P  H  Y      
           
   2641   ATATAGTTTTTAATTACAAGGGCAATAAATCATTTGAACAAATGGACGAAATGGCAAGAG 
          H  I  V  F  N  Y  K  G  N  K  S  F  E  Q  M  D  E  M  A  R      
           
   2701   CTTTAAGGGCACCGATTCCTGAAAGAATAAGTGGTTTAACTGGTGCTGTTAGATATTTAA 
          A  L  R  A  P  I  P  E  R  I  S  G  L  T  G  A  V  R  Y  L      
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   2761   CGCATATGGATAATCCTGAAAAGTATCAATACGATAATACAGAAATACAAGTGTTTGGTG 
          T  H  M  D  N  P  E  K  Y  Q  Y  D  N  T  E  I  Q  V  F  G      
           
   2821   GATTTGACCTTGAAAGTTGTTTAGCGTTATCTACTGGTGATAAAAGACAAGCGTTAAAAG 
          G  F  D  L  E  S  C  L  A  L  S  T  G  D  K  R  Q  A  L  K      
           
   2881   AAATGCTTGGTTTTATTTCGGATAACAATATTATGCATTTAAAAGATTTTGCTGATTATT 
          E  M  L  G  F  I  S  D  N  N  I  M  H  L  K  D  F  A  D  Y      
            
   2941   GTATGTCTGACCGAGCTCCTGCTGGTTGGTTCGAATTGCTAACAGAGAGGAATACTCTTT 
          C  M  S  D  R  A  P  A  G  W  F  E  L  L  T  E  R  N  T  L      
            
3001 TTATAAAAGAGTACATAAAATCGAATTGGCAAAAAGAAAACCAAGTTTATAAAGAGTGAG 
          F  I  K  E  Y  I  K  S  N  W  Q  K  E  N  Q  V  Y  K  E  * 
 
Fig. 2:
 Detailed DNA sequence of pLFE1 replication region. Inverted repeats (IR) are underlined and direct repeats 
(DR) are double underlined. The RSB-region of the putative sso is shown in bold and the dso nic site is indicated by an 
arrow. The deduced amino acid sequences of CopG and RepB are shown and putative –35 and –10 promoter boxes and 
ribosome binding sites (RBS) are underlined with a slashed line. The start and stop codons are marked in bold as are the 
three conserved motifs of repB. The putative promoter and terminator region of the ctRNA are shaded.  
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Motif I Motif II       Motif III
pLFE1 29 RNWWIVVYPESLP  71 KP-HYHIVFN 109 AVRYLTHM
pWV01 10 RNFGFLLYPDSIP  66 KKPHYHVIYI 109 SYEYLTHE
pCI411 17 RNWSWIVYPESAP  62 KP-HWHIIIS 100 SVQYLWHR
pLA106 13 RNWTFVLYPESAT  57 KP-HWHIAMF  95 MIRYFAHM
pE194 19 RNWTFVLYPESAK  63 KE-HYHILVM 101 LVRYMLHM
pLB4 29 RNWGIVVYPESLP  71 KS-HYHLVLN 109 AVRYLTHM
pHPK255   27 KAFGFIIYPESAT  62 KP-HFHAIIV 114 AYEYFTHS
pHP489 43 RHWTILIYPESVN  89 KP-HHHLLLV 129 FYEYLTHK
pA1 13 RDWTFIVYPESAP  57 KS-HYHILLT  95 FSVVIWHI
pPSC22 10 RNFGFLLYPDSIP  66 KKPHYHVIYI 109 SYEYLTHE
 
Fig. 3:
 Multiple sequence alignment of RepB proteins belonging to Rep_2 plasmid replication proteins (pfam01719) in 
the conserved domain database (CDD). Motifs typical of plasmid family pMV158 are shown according to (Ilyina and 
Koonin 1992). Numbers to the left indicate the position of the motifs in each plasmid. 
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pLFE1-copG 12  VEKKKVTLSLPVESNDKLEKMAQKY GMT KSGLVTFLINQADDKG 63  
pLB4-repA  4  VEKKKITLSIPVETNGKLEELAQKY GMT KSGLVNFLVNQVAEAG 55 
pMV158-copG  1   MKKRLTITLSESVLENLEKMAREM GLS KSAMISVALENYKKGQ 51 
pHD2-ORFB   1    MVRVNTRISKKLNDWLDEYSKES GVP KSTLVHLALENYVNQK 50  
pCB101-repC  1     MRVNISIPDEVKQFFEDYSKKT GVP QSSLMALALSEYKDKI 49  
pFX2-copX  5  ESKKRVMISLTKEQDKKLTDMAKQK GFS KSAVAALAIEEYA-RK 57  
pHT926-unknown  5  QERERMQIRLSKTNMQRLQDMAGRY GMS ANSLVSYILGQWLDNN 56  
pRN2-copG   3  STKPNVHIRLREEERKLLKEIAQKY DIS ESDVVKIALKKLAREL 54  
pE194-cop6  8  EKKVAVTLRLTTEENEILNRIKEKY NIS KSDATGILIKKYAKEE 59  
pA1-repA  1  MERVKVGITLTEDTLARLEEICKEM GLS KSQALSMLVNKEYLEK 52  
pLA106-repA  2  TEKKRLTVSFSHKIANQLEELAKDQ GLT KSGLLTVLISKEIERK 53  
        helix B    turn            helix A         strand I  
 
Fig. 4:
 Multiple sequence alignment of CopG proteins belonging to RHH_1 ribbon-helix-helix CopG repressor proteins 
(pfam01402) in the conserved domain database (CDD). The glycine residues mediating the turn between the two helices 
are framed and grey markings are conserved positions with hydrophobic residues (after (Gomis-Ruth et al. 1998). 
Numbers to the left and right indicate the aligned start and end position of the protein sequences.  
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             -35         .         . -10     .         .         . 
 3241 CCACCTTTACGAAGTAAAGTATAGTGGGTTATACTTTGCATGGAAGCTGTCCCGAAGTTa   
      ============================================================ 
      GGTGGAAATGCTTCATTTCATATCACCCAATATGAAACGTACCTTCGACAGGGCTTCAAT 
                                     
               .         .         .         .         .         . 
 3301 ggagTGTTTATATGTCATTTGTAGTGGCGAGAATGCAGAAGGTAAAATCAGGAAATTTAG 
                  M  S  F  V  V  A  R  M  Q  K  V  K  S  G  N  L     
      ============================================================ 
      CCTCACAAATATACAGTAAACATCACCGCTCTTACGTCTTCCATTTTAGTCCTTTAAATC 
 
               .      Motif I      .         .         .         . 
 3361 TTGGGGTAGGTAATCATAATCAGAGAAATACAGACAATCATTCCAACAAAGATATTGATG 
      V  G  V  G  N  H  N  Q  R  N  T  D  N  H  S  N  K  D  I  D     
      ============================================================ 
      AACCCCATCCATTAGTATTAGTCTCTTTATGTCTGTTAGTAAGGTTGTTTCTATAACTAC 
                                                                    
               .         Motif II  .         .         .         . 
 3421 TTGAACGGTCACATTTAAATTATGATTTGGTCAATCGGACAGAAAATTATAAACGAGATA 
      V  E  R  S  H  L  N  Y  D  L  V  N  R  T  E  N  Y  K  R  D     
      ============================================================ 
      AACTTGCCAGTGTAAATTTAATACTAAACCAGTTAGCCTGTCTTTTAATATTTGCTCTAT 
                                                                 
               .         .         .         .         .         . 
 3481 TTGAGCAATTTATTAACGACAACAAATCAAGTAGTCGTGCTGTCAGAAAAGATGCTGTAT 
      I  E  Q  F  I  N  D  N  K  S  S  S  R  A  V  R  K  D  A  V     
      ============================================================ 
      AACTCGTTAAATAATTGCTGTTGTTTAGTTCATCAGCACGACAGTCTTTTCTACGACATA 
                    
               .         .         .         .         .         . 
      TAATAAACGAAAGAGTACTTTAAAGATTCTAAGCAAGTTACAACTGAACAGGTTAAAACG 
3541  L  I  N  E  R  V  L  *                                          
      ============================================================ 
      ATTATTTGCTTTCTCATGAAATTTCTAAGATTCGTTCAATGTTGACTTGTCCAATTTTGC 
                                                             
               .         .         .         .         .         . 
      CTTGTTAGTGGCGTTTTAGACAAAGTAAAAGAATTTGTAAAAGGTGGAGAATTTGAAAAA 
 3601                          V  K  E  F  V  K  G  G  E  F  E  K    
      ============================================================ 
      GAACAATCACCGCAAAATCTGTTTCATTTTCTTAAACATTTTCCACCTCTTAAACTTTTT 
                             
               .         .         .         .         .         . 
      ATTCATAGAAATGAAACTCAAACACGAGATAGAGATGAATTAAGTCGTTAGAAGCTCATA 
 3661  I  H  R  N  E  T  Q  T  R  D  R  D  E  L  S  R  *  
      ============================================================ 
      TAAGTATCTTTACTTTGAGTTTGTGCTCTATCTCTACTTAATTCAGCAATCTTCGAGTAT 
 
Fig. 5:
 Sequence analysis of the putative pre/mob2 region of pLFE1. The deduced amino acid sequence and the two 
conserved motifs are indicated as is the amino acid sequence corresponding to the small pre/mob carboxyl-terminal 
fragment. The putative RBS is indicated in small letters and predicted –10 and –35 promoter box sequences are 
underlined. The nucleotide sequence written in bold is the potential oriT region, which includes the IR forming the 
hairpin structure and the nic site, indicated in italic and with an arrow, respectively. 
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6. Conclusions and discussion  
The Lactobacillus plantarum strains chosen for testing in this project were naturally occurring wild-
type strains recently isolated from Belgian fermented sausages and from a French raw-milk cheese. 
The strains harboured transferable plasmids conferring resistance to the important human drugs 
tetracycline and erythromycin. This work includes data documenting transfer of these native 
plasmids to Enterococcus faecalis - an opportunistic pathogen and a common inhabitant of the 
microbiota in the human gastrointestinal tract. Earlier studies have reported antibiotic resistance 
gene transfer from Lactobacillus reuteri strains to Enterococcus faecium in similar environments. 
However, these have focused on transfer of the broad-host-range conjugative plasmid pAMβ1 
originating from Streptococcus, which was introduced to the Lactobacillus donors (McConnell et 
al. 1991;Morelli et al. 1988). The present results therefore add important aspects to assessment of 
antibiotic resistance dissemination from lactobacilli in the food chain, namely wild-type plasmids 
and naturally occurring bacteria.  
Different transfer potentials were observed for the three model donor strains in the GI tract using di-
associated rats as models. However, the extent of dissemination in vivo did not correlate with 
transfer frequencies observed in filter-mating experiments. Higher numbers of transconjugants were 
namely isolated from faecal samples using the L. plantarum M345 donor strain with lower in vitro 
transfer frequency compared to L. plantarum strain DG507 and DG522 with higher in vitro 
frequencies. These results not surprisingly indicate that in vitro mating provides invalid estimates of 
the transfer potential in vivo. This finding may reflect a number of intestinal factors influencing the 
donor strain as well as the plasmid itself, recipients and transconjugants and thereby the transfer rate 
in the gastrointestinal environment. Yet, the three donor strains attained different population 
densities in vivo, possibly accounting for some of the observed plasmid dissemination divergences. 
The background for this could be variable adaptability of the donors to the gastrointestinal 
environment. Although the three donor strains reached different densities in the GI tract, their 
numbers however, seemed to remain relatively stable without re-administration. Strain L. plantarum 
M345 decreased approximately one log unit soon after last administration and thereafter stayed 
constant for 12 days before the experiment was ended. The stability of strain DG507 and DG522 
was only observed for three days without donor administration, but lack of administration during 
this time period did not alter population densities. In all cases, transconjugants also maintained 
stable population sizes throughout experiments, once their numbers had increased to specific levels.  
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Treatment with erythromycin at concentrations intended to simulate clinical doses or 1/10 of 
clinical doses resulted in a practically complete conversion of recipients into transconjugants when 
using L. plantarum M345 as donor in in vivo studies. The very fast “turn-over” of the recipient 
population suggested an increased transfer frequency induced by erythromycin. Hence, spread of 
plasmid pLFE1 by vertical dissemination (i.e. by selection for the transconjugants and growth at 
expense of the recipients) was considered to have longer time perspectives than observed for the 
actual transformation. Filter-mating studies also resulted in higher numbers of transconjugants on 
media supplemented with medium concentrations of erythromycin compared to negative controls, 
thus supporting this hypothesis. However, more reliable evidence could be obtained by repetition of 
the in vitro mating study with mating time reduced to a few hours. Thereby the potential bias of 
selective growth occurring during mating over night could be controlled.  
Induction of conjugal transfer by erythromycin is an effect that has not been reported earlier. Such 
effect considerably enhances the risk associated with plasmid pLFE1. Hence in this situation 
selective pressure by erythromycin would increase the vertical as well as the horizontal 
dissemination. Subsequently, more studies are required to confirm or discard this effect and in 
confirming case elucidate the mechanisms behind.  
 
A relatively high dissemination rate was observed in all experiments conducted on di-associated 
rats, representing worst-case scenarios for transfer. In contrast, no transfer could be detected to an 
inoculated E. faecalis recipient in a similar experimental set-up using streptomycin-treated mice and 
L. plantarum M345 as donor. Streptomycin-treated mice represent a model with an indigenous 
microbiota and thus a larger colonization barrier compared to di-associated rats. This situation was 
reflected by the lower population numbers of inoculated donors and recipients in the streptomycin-
treated mice compared to the di-associated rats. Lacking evidence of transfer in the mouse model 
demonstrates the powerful control exerted by the indigenous microbiota even in a state impaired by 
streptomycin. However, transfer to the indigenous microbiota was not investigated, and potential 
recipients adapted to the gastrointestinal environment may have received the plasmid.  
The host-range of plasmid pLFE1 was investigated in filter-mating experiments with L. plantarum 
M345 as donor strain. A relatively broad selection of bacterial genera including E. faecalis, 
Lactobacillus rhamnosus, Lactococcus lactis, Listeria monocytogenes and Listeria innocua was 
shown to accept the plasmid. However, transfer of pLFE1 could not be detected by filter-mating 
from E. faecalis transconjugants to isogenic recipients of E. faecalis. Secondary transfer of pLFE1 
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from transconjugants to new recipients cannot be rejected on this basis, since transfer may be 
feasible either from other transconjugants, under alternative conditions or to other recipients. Yet, 
analysis of the pLFE1 nucleotide sequence supported the in vitro mating results with finding of only 
a putative truncated and presumably non-functional mobilization protein. Hence, transfer of pLFE1 
from other donors than L. plantarum M345 may be severely restricted since not only the presence 
of tra genes responsible for mating-pair formation but also a mobilization protein compatible with 
the pLFE1 origin of transfer is required in trans. These functions are apparently present on other 
mobile elements harboured by strain M345, but a similar constellation may be less likely in other 
new hosts.  
 
In conclusion, the extent of antibiotic resistance transfer from ingested Lactobacillus strains 
transiently passing the intestine probably will be negligible in most healthy humans. Nevertheless, 
the risk persists for adaptation of Lactobacillus-derived mobile antibiotic resistance determinants 
into the human gastrointestinal microbiota. The colonization barrier in different human individuals 
is rather variable and in some individuals, colonization of ingested Lactobacillus strains may be 
allowed. This in turns expands time where interruptions of the microbiota may occur and increases 
risk of a pathogen receiving the resistance plasmid or conditions selective for the plasmid being 
imposed. The same scenario can be asserted if an initial transfer event allows integration of the 
resistance determinant into an existing member of the indigenous microbiota. Once established in a 
population, the resistance plasmid is often maintained even if it is only as a small sub-population. 
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8. Appendix 
PLFE1  4031 bp  - plasmid isolated from Lactobacillus plantarum 
 
                                    
      1        .         .         .         .         .         . 
      GGGGTCCCGAGCGCCTACGAGGAATTTGTATCGATAAGAAATAGATTTAAAAATTTCGCT 
      ============================================================ 
      CCCCAGGGCTCGCGGATGCTCCTTAAACATAGCTATTCTTTATCTAAATTTTTAAAGCGA 
              
     61        .         .         .         .         .         . 
      GTTATTTTGTACATTTAACTTGACGGTGACATCTCTCTATTGTGAGTTATTAGTGGTACA 
      ============================================================ 
      CAATAAAACATGTAAATTGAACTGCCACTGTAGAGAGATAACACTCAATAATCACCATGT 
 
    121        .         .         .         .         .         . 
      GTTTTCAACCGTTTTAATTATAAAAAAGTGGTGCATTTTTAAATTGGCACAAACAGGTAA 
      ============================================================ 
      CAAAAGTTGGCAAAATTAATATTTTTTCACCACGTAAAAATTTAACCGTGTTTGTCCATT 
     
    181        .         .         .         .         .         . 
      CGGTTATTGCAGGTGTATTTCTTATCTATGGGTTTAACATGGATTTTATCATTAAAATCA 
      ============================================================ 
      GCCAATAACGTCCACATAAAGAATAGATACCCAAATTGTACCTAAAATAGTAATTTTAGT 
 
    241        .         .         .         .         .         . 
      TGAGTATTGTCCGAGAGTGATTGGTCTTGCGTATGGTTAACCCTAAAGTTATGGAAATAA 
      ============================================================ 
      ACTCATAACAGGCTCTCACTAACCAGAACGCATACCAATTGGGATTTCAATACCTTTATT 
 
    301        .         .         .         .         .         . 
      GACTTAGAAGCAAACTTAAGAGTGTGTTGATAGTGCATTATCTTAAAATTTTGTATAATA 
      ============================================================ 
      CTGAATCTTCGTTTGAATTCTCACACAACTATCACGTAATAGAATTTTAAAACATATTAT 
 
    361        .         .         .         .         .         . 
      GGAATTGAAGTTAAATTAGATGCTAAAAATTTGTAATTAAGAAGGAGGGATTCGTCATGT 
      ============================================================ 
      CCTTAACTTCAATTTAATCTACGATTTTTAAACATTAATTCTTCCTCCCTAAGCAGTACA 
  
    421        .         .         .         .         .         . 
      TGGTATTCCAAATGCGTAATGTAGATAAAACATCTACTGTTTTGAAACAGACTAAAAACA 
      ============================================================ 
      ACCATAAGGTTTACGCATTACATCTATTTTGTAGATGACAAAACTTTGTCTGATTTTTGT 
  
    481        .         .         .         .         .         . 
      GTGATTACGCAGATAAATAAATACGTTAGATTAATTCCTACCAGTGACTAATCTTATGAC 
      ============================================================ 
      CACTAATGCGTCTATTTATTTATGCAATCTAATTAAGGATGGTCACTGATTAGAATACTG 
 
    541        .         .         .         .         .         . 
      TTTTTAAACAGATAACTAAAATTACAAACAAATCGTTTAACTTCTGTATTTGTTTATAGA 
      ============================================================ 
      AAAAATTTGTCTATTGATTTTAATGTTTGTTTAGCAAATTGAAGACATAAACAAATATCT 
              
     
     
 
 
 110
    601        .         .         .         .         .         . 
      TGTAATCACTTCAGGAGAGATTACATGAACAAAAATATAAAATATTCTCAAAACTTTTTA 
      ============================================================ 
      ACATTAGTGAAGTCCTCTCTAATGTACTTGTTTTTATATTTTATAAGAGTTTTGAAAAAT 
 
    661        .         .         .         .         .         . 
      ACGAGTGAAAAAGTACTCAACCAAATAATAAAACAATTGAATTTAAAAGAAACCGATACC 
      ============================================================ 
      TGCTCACTTTTTCATGAGTTGGTTTATTATTTTGTTAACTTAAATTTTCTTTGGCTATGG 
 
    721        .         .         .         .         .         . 
      GTTTACGAAATTGGAACAGGTAAAGGGCATTTAACGACGAAACTGGCTAAAATAAGTAAA 
      ============================================================ 
      CAAATGCTTTAACCTTGTCCATTTCCCGTAAATTGCTGCTTTGACCGATTTTATTCATTT 
 
    781        .         .         .         .         .         . 
      CAGGTAACGTCTATTGAATTAGACAGTCATCTATTCAACTTATCGTCAGAAAAATTAAAA 
      ============================================================ 
      GTCCATTGCAGATAACTTAATCTGTCAGTAGATAAGTTGAATAGCAGTCTTTTTAATTTT 
 
    841        .         .         .         .         .         . 
      CTGAATACTCGTGTCACTTTAATTCACCAAGATATTCTACAGTTTCAATTCCCTAACAAA 
      ============================================================ 
      GACTTATGAGCACAGTGAAATTAAGTGGTTCTATAAGATGTCAAAGTTAAGGGATTGTTT 
 
    901        .         .         .         .         .         . 
      CAGAGGTATAAAATTGTTGGGAATATTCCTTACCATTTAAGCACACAAATTATTAAAAAA 
      ============================================================ 
      GTCTCCATATTTTAACAACCCTTATAAGGAATGGTAAATTCGTGTGTTTAATAATTTTTT 
 
    961        .         .         .         .         .         . 
      GTGGTTTTTGAAAGCCATGCGTCTGACATCTATCTGATTGTTGAAGAAGGATTCTACAAG 
      ============================================================ 
      CACCAAAAACTTTCGGTACGCAGACTGTAGATAGACTAACAACTTCTTCCTAAGATGTTC 
 
   1021        .         .         .         .         .         . 
      CGTACCTTGGATATTCACCGAACACTAGGGTTGCTCTTGCACACTCAAGTCTCGATTCAG 
      ============================================================ 
      GCATGGAACCTATAAGTGGCTTGTGATCCCAACGAGAACGTGTGAGTTCAGAGCTAAGTC 
 
   1081        .         .         .         .         .         . 
      CAATTGCTTAAGCTGCCAGCGGAATGCTTTCATCCTAAACCAAAAGTAAACAGTGTCTTA 
      ============================================================ 
      GTTAACGAATTCGACGGTCGCCTTACGAAAGTAGGATTTGGTTTTCATTTGTCACAGAAT 
 
   1141        .         .         .         .         .         . 
      ATAAAACTTACCCGCCATACCACAGATGTTCCAGATAAATATTGGAAGCTATATACGTAC 
      ============================================================ 
      TATTTTGAATGGGCGGTATGGTGTCTACAAGGTCTATTTATAACCTTCGATATATGCATG 
 
   1201        .         .         .         .         .         . 
      TTTGTTTCAAAATGGGTCAATCGAGAATATCGTCAACTGTTTACTAAAAATCAGTTTCAT 
      ============================================================ 
      AAACAAAGTTTTACCCAGTTAGCTCTTATAGCAGTTGACAAATGATTTTTAGTCAAAGTA 
 
   1261        .         .         .         .         .         . 
      CAAGCAATGAAACACGCCAAAGTAAACAATTTAAGTACCGTTACTTATGAGCAAGTATTG 
      ============================================================ 
      GTTCGTTACTTTGTGCGGTTTCATTTGTTAAATTCATGGCAATGAATACTCGTTCATAAC 
 111
 
   1321        .         .         .         .         .         . 
      TCTATTTTTAATAGTTATCTATTATTTAACGGGAGGAAATAATTCTATGAGTCGCTTTTG 
      ============================================================ 
      AGATAAAAATTATCAATAGATAATAAATTGCCCTCCTTTATTAAGATACTCAGCGAAAAC 
 
   1381        .         .         .         .         .         . 
      TAAATGTTGGAGAAAGAGAATAAATCGCTTAAAAACGAAATTAAGGGCATTTACAGAGGT 
      ============================================================ 
      ATTTACAACCTCTTTCTCTTATTTAGCGAATTTTTGCTTTAATTCCCGTAAATGTCTCCA 
 
   1441        .         .         .         .         .         . 
      TTTAATCAGTTTATGGAAAATACCCTTGGTGCAACTGTTGGACAAGCTAAAAAGCTCATG 
      ============================================================ 
      AAATTAGTCAAATACCTTTTATGGGAACCACGTTGACAACCTGTTCGATTTTTCGAGTAC 
 
   1501        .         .         .         .         .         . 
      AATAACCTTGTGAGCGAAATTAAAGAGTTTGTAAAAGGTGGAGAGTTTGAAAAAATTCAT 
      ============================================================ 
      TTATTGGAACACTCGCTTTAATTTCTCAAACATTTTCCACCTCTCAAACTTTTTTAAGTA 
 
   1561        .         .         .         .         .         . 
      AGAAATGAAACTCGAACACGAGATAGAGATGAATTAAGTCGTTAGAAGCTCATATTTGCG 
      ============================================================ 
      TCTTTACTTTGAGCTTGTGCTCTATCTCTACTTAATTCAGCAATCTTCGAGTATAAACGC 
 
   1621        .         .         .         .         .         . 
      TTTTAAGGCGTTTTAAATCAATTCGAGTATATTTATACCTGTTTGGTCTTTTCGTCGGCA 
      ============================================================ 
      AAAATTCCGCAAAATTTAGTTAAGCTCATATAAATATGGACAAACCAGAAAAGCAGCCGT 
 
   1681        .         .         .         .         .         . 
      TAAGCGTTAAAAATGGCAATAGAAAAAGCAGCAAGGGCGAACGTAGTGAGTGCATTTACC 
      ============================================================ 
      ATTCGCAATTTTTACCGTTATCTTTTTCGTCGTTCCCGCTTGCATCACTCACGTAAATGG 
 
   1741        .         .         .         .         .         . 
      CTTGCTGCTTTTTTTGTTGTCATTTAGCTTTTGCATAGACGACGGAAAGCCAACAGGTGT 
      ============================================================ 
      GAACGACGAAAAAAACAACAGTAAATCGAAAACGTATCTGCTGCCTTTCGGTTGTCCACA 
 
   1801        .         .         .         .         .         . 
      GAATGTTTAGCTACTTTTCAGAGGCATGATCAAACGCATTGCGTTTGTGGGTGTGGGCAA 
      ============================================================ 
      CTTACAAATCGATGAAAAGTCTCCGTACTAGTTTGCGTAACGCAAACACCCACACCCGTT 
 
   1861        .         .         .         .         .         . 
      CGCCCGCGGTTTTATTAGTTTTTAGGAATTGGGAAGCAAACTGGGGGGAGATTTTGAAAA 
      ============================================================ 
      GCGGGCGCCAAAATAATCAAAAATCCTTAACCCTTCGTTTGACCCCCCTCTAAAACTTTT 
 
   1921        .         .         .         .         .         . 
      AATCGACCAACTCATGGGGGCACTACGACACCCCCCATGTGTCCATTGTCCATTGTCCAA 
      ============================================================ 
      TTAGCTGGTTGAGTACCCCCGTGATGCTGTGGGGGGTACACAGGTAACAGGTAACAGGTT 
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   1981        .         .         .         .         .         . 
      ATAGATAAAAAGATTAAATGTCTTGTAAATACCTTTATATGAACGTTTTAAGCACCTATT 
      ============================================================ 
      TATCTATTTTTCTAATTTACAGAACATTTATGGAAATATACTTGCAAAATTCGTGGATAA 
 
   2041        .         .         .         .         .         . 
      TCGAGGTGAAAAAAAGTTTTTTGTAAAATCTTGTATTCCTGTCGTATGTATAATATAATT 
      ============================================================ 
      AGCTCCACTTTTTTTCAAAAAACATTTTAGAACATAAGGACAGCATACATATTATATTAA 
 
   2101        .         .         .         .         .         . 
      ACAGTGTAAAAGAGATTTTGAAGAGAATTGAGGTGTATTTTGTGGTTGAAGTTGAGAAGA 
      ============================================================ 
      TGTCACATTTTCTCTAAAACTTCTCTTAACTCCACATAAAACACCAACTTCAACTCTTCT 
 
   2161        .         .         .         .         .         . 
      AAAAAGTGACTTTATCTTTACCTGTTGAATCGAATGACAAACTAGAAAAAATGGCACAAA 
      ============================================================ 
      TTTTTCACTGAAATAGAAATGGACAACTTAGCTTACTGTTTGATCTTTTTTACCGTGTTT 
 
   2221        .         .         .         .         .         . 
      AATATGGAATGACTAAATCAGGTTTGGTTACATTTTTAATTAATCAAGCTGATGATAAGG 
      ============================================================ 
      TTATACCTTACTGATTTAGTCCAAACCAATGTAAAAATTAATTAGTTCGACTACTATTCC 
 
   2281        .         .         .         .         .         . 
      GGACTATTTTTAAATAAAAAAAGCCCTGCTAGGAAGATAGCAAGGGCTCGCAAGATTTGG 
      ============================================================ 
      CCTGATAAAAATTTATTTTTTTCGGGACGATCCTTCTATCGTTCCCGAGCGTTCTAAACC 
 
   2341        .         .         .         .         .         . 
      TTTTCTTTGATTTCGCAACTCAAGTTTATCAAATTTTCCCTTGTTTTCCTAGTAGAGTAA 
      ============================================================ 
      AAAAGAAACTAAAGCGTTGAGTTCAAATAGTTTAAAAGGGAACAAAAGGATCATCTCATT 
 
   2401        .         .         .         .         .         . 
      CTAGGAAGGTGTAGAAAAATATGGAAAATGAAAATAGAACAGATTGGACATTGCCTAGAA 
      ============================================================ 
      GATCCTTCCACATCTTTTTATACCTTTTACTTTTATCTTGTCTAACCTGTAACGGATCTT 
 
   2461        .         .         .         .         .         . 
      AGAATTTAAATCCAAAAACTAAACAGCCTTATAAGCGAGGTCGTAACTGGTGGATTGTTG 
      ============================================================ 
      TCTTAAATTTAGGTTTTTGATTTGTCGGAATATTCGCTCCAGCATTGACCACCTAACAAC 
 
   2521        .         .         .         .         .         . 
      TTTATCCTGAAAGTTTGCCAGAGAATTGGAAAGAGATTATTTCAACTGAACCTGTGGCAA 
      ============================================================ 
      AAATAGGACTTTCAAACGGTCTCTTAACCTTTCTCTAATAAAGTTGACTTGGACACCGTT 
 
   2581        .         .         .         .         .         . 
      TTAGTCCATTACATGATAAAGATGTTAATGCAGACGGAACAAAGAAAAAGCCGCATTATC 
      ============================================================ 
      AATCAGGTAATGTACTATTTCTACAATTACGTCTGCCTTGTTTCTTTTTCGGCGTAATAG 
 
   2641        .         .         .         .         .         . 
      ATATAGTTTTTAATTACAAGGGCAATAAATCATTTGAACAAATGGACGAAATGGCAAGAG 
      ============================================================ 
      TATATCAAAAATTAATGTTCCCGTTATTTAGTAAACTTGTTTACCTGCTTTACCGTTCTC 
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   2701        .         .         .         .         .         . 
      CTTTAAGGGCACCGATTCCTGAAAGAATAAGTGGTTTAACTGGTGCTGTTAGATATTTAA 
      ============================================================ 
      GAAATTCCCGTGGCTAAGGACTTTCTTATTCACCAAATTGACCACGACAATCTATAAATT 
 
   2761        .         .         .         .         .         . 
      CGCATATGGATAATCCTGAAAAGTATCAATACGATAATACAGAAATACAAGTGTTTGGTG 
      ============================================================ 
      GCGTATACCTATTAGGACTTTTCATAGTTATGCTATTATGTCTTTATGTTCACAAACCAC 
 
   2821        .         .         .         .         .         . 
      GATTTGACCTTGAAAGTTGTTTAGCGTTATCTACTGGTGATAAAAGACAAGCGTTAAAAG 
      ============================================================ 
      CTAAACTGGAACTTTCAACAAATCGCAATAGATGACCACTATTTTCTGTTCGCAATTTTC 
 
   2881        .         .         .         .         .         . 
      AAATGCTTGGTTTTATTTCGGATAACAATATTATGCATTTAAAAGATTTTGCTGATTATT 
      ============================================================ 
      TTTACGAACCAAAATAAAGCCTATTGTTATAATACGTAAATTTTCTAAAACGACTAATAA 
 
   2941        .         .         .         .         .         . 
      GTATGTCTGACCGAGCTCCTGCTGGTTGGTTCGAATTGCTAACAGAGAGGAATACTCTTT 
      ============================================================ 
      CATACAGACTGGCTCGAGGACGACCAACCAAGCTTAACGATTGTCTCTCCTTATGAGAAA 
 
   3001        .         .         .         .         .         . 
      TTATAAAAGAGTACATAAAATCGAATTGGCAAAAAGAAAACCAAGTTTATAAAGAGTGAG 
      ============================================================ 
      AATATTTTCTCATGTATTTTAGCTTAACCGTTTTTCTTTTGGTTCAAATATTTCTCACTC 
 
   3061        .         .         .         .         .         . 
      GAATTAAATAAAAAATATGCCCCCTGCTGAAAAGCCAAGGGGGTTATTTTTTTGTGTTTT 
      ============================================================ 
      CTTAATTTATTTTTTATACGGGGGACGACTTTTCGGTTCCCCCAATAAAAAAACACAAAA 
 
   3121        .         .         .         .         .         . 
      AAGAGTTGGATTACATGAGCCAACTCTTTGTTTTTTGTATCAGCTAATTGCACCATAAGG 
      ============================================================ 
      TTCTCAACCTAATGTACTCGGTTGAGAAACAAAAAACATAGTCGATTAACGTGGTATTCC 
 
   3181        .         .         .         .         .         . 
      GTGCGCTGATACTCGGCTCAAAAGAGCCGAATAAGCCGTCTGCAAGACCCCTCGGCGAGC 
      ============================================================ 
      CACGCGACTATGAGCCGAGTTTTCTCGGCTTATTCGGCAGACGTTCTGGGGAGCCGCTCG 
 
   3241        .         .         .         .         .         . 
      CCACCTTTACGAAGTAAAGTATAGTGGGTTATACTTTGCATGGAAGCTGTCCCGAAGTTA 
      ============================================================ 
      GGTGGAAATGCTTCATTTCATATCACCCAATATGAAACGTACCTTCGACAGGGCTTCAAT 
 
   3301        .         .         .         .         .         . 
      GGAGTGTTTATATGTCATTTGTAGTGGCGAGAATGCAGAAGGTAAAATCAGGAAATTTAG 
      ============================================================ 
      CCTCACAAATATACAGTAAACATCACCGCTCTTACGTCTTCCATTTTAGTCCTTTAAATC 
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   3361        .         .         .         .         .         . 
      TTGGGGTAGGTAATCATAATCAGAGAAATACAGACAATCATTCCAACAAAGATATTGATG 
      ============================================================ 
      AACCCCATCCATTAGTATTAGTCTCTTTATGTCTGTTAGTAAGGTTGTTTCTATAACTAC 
 
   3421        .         .         .         .         .         . 
      TTGAACGGTCACATTTAAATTATGATTTGGTCAATCGGACAGAAAATTATAAACGAGATA 
      ============================================================ 
      AACTTGCCAGTGTAAATTTAATACTAAACCAGTTAGCCTGTCTTTTAATATTTGCTCTAT 
 
   3481        .         .         .         .         .         . 
      TTGAGCAATTTATTAACGACAACAAATCAAGTAGTCGTGCTGTCAGAAAAGATGCTGTAT 
      ============================================================ 
      AACTCGTTAAATAATTGCTGTTGTTTAGTTCATCAGCACGACAGTCTTTTCTACGACATA 
 
   3541        .         .         .         .         .         . 
      TAATAAACGAAAGAGTACTTTAAAGATTCTAAGCAAGTTACAACTGAACAGGTTAAAACG 
      ============================================================ 
      ATTATTTGCTTTCTCATGAAATTTCTAAGATTCGTTCAATGTTGACTTGTCCAATTTTGC 
 
   3601        .         .         .         .         .         . 
      CTTGTTAGTGGCGTTTTAGACAAAGTAAAAGAATTTGTAAAAGGTGGAGAATTTGAAAAA 
      ============================================================ 
      GAACAATCACCGCAAAATCTGTTTCATTTTCTTAAACATTTTCCACCTCTTAAACTTTTT 
 
   3661        .         .         .         .         .         . 
      ATTCATAGAAATGAAACTCAAACACGAGATAGAGATGAATTAAGTCGTTAGAAGCTCATA 
      ============================================================ 
      TAAGTATCTTTACTTTGAGTTTGTGCTCTATCTCTACTTAATTCAGCAATCTTCGAGTAT 
    
   3721        .         .         .         .         .         . 
      TTTGCGTTCTAAGACGTTTTAAATCAATTCGAGTATATTTACACGTGATTATTACTTTTC 
      ============================================================ 
      AAACGCAAGATTCTGCAAAATTTAGTTAAGCTCATATAAATGTGCACTAATAATGAAAAG 
 
   3781        .         .         .         .         .         . 
      GTCGGCATAAGCGTTTAAAATGGCTATAAATAATAAAGACAAGGGCGAACAACGTGAGCA 
      ============================================================ 
      CAGCCGTATTCGCAAATTTTACCGATATTTATTATTTCTGTTCCCGCTTGTTGCACTCGT 
 
   3841        .         .         .         .         .         . 
      ACGTTTACCCTTGTCTTTTTATTTTAGGCATTTAGCTTTTGCTGAGCGACGAAAAGTAAT 
      ============================================================ 
      TGCAAATGGGAACAGAAAAATAAAATCCGTAAATCGAAAACGACTCGCTGCTTTTCATTA 
 
   3901        .         .         .         .         .         . 
      TACGTGATAAAGCTACTTTTCAGAGGCATGATCAAACGCATTGCGTTTGTCAGGGGTGGG 
      ============================================================ 
      ATGCACTATTTCGATGAAAAGTCTCCGTACTAGTTTGCGTAACGCAAACAGTCCCCACCC 
 
   3961        .         .         .         .         .         . 
      CGGAAGCCCACGGTTTTTAAAAGGGTTTTTGCGGAGCAAAATACCCTTTTCTTCTTATCT 
      ============================================================ 
      GCCTTCGGGTGCCAAAAATTTTCCCAAAAACGCCTCGTTTTATGGGAAAAGAAGAATAGA 
 
   4021        .4031    
      TGATACTATTA 
      =========== 
      ACTATGATAAT 
